{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:28:35Z","timestamp":1781018915228,"version":"3.54.1"},"reference-count":309,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000040","name":"American Parkinson's Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007027","name":"Leon Levy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS113960"],"award-info":[{"award-number":["R01NS113960"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol. Neurodegener. Adv."],"DOI":"10.1186\/s44477-026-00038-9","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:47:07Z","timestamp":1781016427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Propagation of \u03b1-synuclein pathology: models, mechanisms and future goals"],"prefix":"10.1186","volume":"2","author":[{"given":"Aryeh","family":"Zolin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Xin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Burr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"3","key":"38_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V. Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 2023;14(3):176. https:\/\/doi.org\/10.1038\/s41419-023-05672-9.","journal-title":"Cell Death Dis"},{"issue":"6","key":"38_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1566-2772(01)00023-8","volume":"1","author":"IVJ Murray","year":"2001","unstructured":"Murray IVJ, Lee VMY, Trojanowski JQ. Synucleinopathies: a pathological and molecular review. Clin Neurosci Res Adv Parkinson\u2019s Dis Res. 2001;1(6):445\u201355. https:\/\/doi.org\/10.1016\/S1566-2772(01)00023-8.","journal-title":"Clin Neurosci Res Adv Parkinson\u2019s Dis Res"},{"issue":"2\u20133","key":"38_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/s0304-3940(98)00407-8","volume":"249","author":"K Wakabayashi","year":"1998","unstructured":"Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett. 1998;249(2\u20133):180\u20132. https:\/\/doi.org\/10.1016\/s0304-3940(98)00407-8.","journal-title":"Neurosci Lett"},{"issue":"1","key":"38_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0304-3940(97)00891-4","volume":"239","author":"K Wakabayashi","year":"1997","unstructured":"Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi H. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson\u2019s disease. Neurosci Lett. 1997;239(1):45\u20138. https:\/\/doi.org\/10.1016\/S0304-3940(97)00891-4.","journal-title":"Neurosci Lett"},{"issue":"6","key":"38_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.neuron.2005.01.032","volume":"45","author":"I Yazawa","year":"2005","unstructured":"Yazawa I, Giasson BI, Sasaki R, Zhang B, Joyce S, Uryu K, et al. Mouse model of multiple system atrophy \u03b1-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron. 2005;45(6):847\u201359. https:\/\/doi.org\/10.1016\/j.neuron.2005.01.032.","journal-title":"Neuron"},{"issue":"38","key":"38_CR6","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB, et al. Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci U S A. 2015;112(38):E5308-17. https:\/\/doi.org\/10.1073\/pnas.1514475112.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6645","key":"38_CR7","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M. \u03b1-Synuclein in Lewy bodies. Nature. 1997;388(6645):839\u201340. https:\/\/doi.org\/10.1038\/42166.","journal-title":"Nature"},{"issue":"11","key":"38_CR8","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. \u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A. 1998;95(11):6469\u201373. https:\/\/doi.org\/10.1073\/pnas.95.11.6469.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"38_CR9","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am J Pathol. 1998;152(4):879\u201384.","journal-title":"Am J Pathol"},{"issue":"6","key":"38_CR10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/jnen\/62.6.644","volume":"62","author":"Y Saito","year":"2003","unstructured":"Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M, et al. Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol. 2003;62(6):644\u201354. https:\/\/doi.org\/10.1093\/jnen\/62.6.644.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"38_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ana.23746","volume":"73","author":"LV Kalia","year":"2013","unstructured":"Kalia LV, Kalia SK, McLean PJ, Lozano AM, Lang AE. \u03b1-Synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol. 2013;73(2):155\u201369. https:\/\/doi.org\/10.1002\/ana.23746.","journal-title":"Ann Neurol"},{"issue":"3","key":"38_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024091","volume":"8","author":"J Burr\u00e9","year":"2018","unstructured":"Burr\u00e9 J, Sharma M, S\u00fcdhof TC. Cell biology and pathophysiology of \u03b1-Synuclein. Cold Spring Harb Perspect Med. 2018;8(3):a024091. https:\/\/doi.org\/10.1101\/cshperspect.a024091.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"38_CR13","doi-asserted-by":"publisher","unstructured":"Song C, Luk K. Alpha-synuclein spreading in Parkinson\u2019s disease. In: Handbook of Behavioral Neuroscience [Internet]. Elsevier; 2025 [cited 2026 Mar 3]. p. 91\u2013104. Available from: https:\/\/www.sciencedirect.com\/science\/chapter\/handbook\/abs\/pii\/B978044321992400004Xhttps:\/\/doi.org\/10.1016\/B978-0-443-21992-4.00004-X","DOI":"10.1016\/B978-0-443-21992-4.00004-X"},{"issue":"6109","key":"38_CR14","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O\u2019Brien P, Trojanowski JQ, et al. Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012;338(6109):949\u201353. https:\/\/doi.org\/10.1126\/science.1227157.","journal-title":"Science"},{"issue":"31","key":"38_CR15","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of \u03b1-synuclein. Proc Natl Acad Sci U S A. 2009;106(31):13010\u20135. https:\/\/doi.org\/10.1073\/pnas.0903691106.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"38_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, et al. Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med. 2008;14(5):501\u20133. https:\/\/doi.org\/10.1038\/nm1746.","journal-title":"Nat Med"},{"issue":"5","key":"38_CR17","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body\u2013like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat Med. 2008;14(5):504\u20136. https:\/\/doi.org\/10.1038\/nm1747.","journal-title":"Nat Med"},{"issue":"1","key":"38_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00441-018-2839-5","volume":"373","author":"W Peelaerts","year":"2018","unstructured":"Peelaerts W, Bousset L, Baekelandt V, Melki R. \u0251-Synuclein strains and seeding in Parkinson\u2019s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences. Cell Tissue Res. 2018;373(1):195\u2013212. https:\/\/doi.org\/10.1007\/s00441-018-2839-5.","journal-title":"Cell Tissue Res"},{"issue":"4","key":"38_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","volume":"16","author":"C Peng","year":"2020","unstructured":"Peng C, Trojanowski JQ, Lee VMY. Protein transmission in neurodegenerative disease. Nat Rev Neurol. 2020;16(4):199\u2013212. https:\/\/doi.org\/10.1038\/s41582-020-0333-7.","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"38_CR20","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.molmed.2020.03.012","volume":"26","author":"N Uemura","year":"2020","unstructured":"Uemura N, Uemura MT, Luk KC, Lee VMY, Trojanowski JQ. Cell-to-cell transmission of tau and \u0251-synuclein. Trends Mol Med. 2020;26(10):936\u201352. https:\/\/doi.org\/10.1016\/j.molmed.2020.03.012.","journal-title":"Trends Mol Med"},{"issue":"1","key":"38_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/2051-5960-1-38","volume":"1","author":"AN Sacino","year":"2013","unstructured":"Sacino AN, Brooks M, McGarvey NH, McKinney AB, Thomas MA, Levites Y, et al. Induction of CNS \u03b1-synuclein pathology by fibrillar and non-amyloidogenic recombinant \u03b1-synuclein. Acta Neuropathol Commun. 2013;1(1):38. https:\/\/doi.org\/10.1186\/2051-5960-1-38.","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"38_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020375","volume":"10","author":"IC Br\u00e1s","year":"2021","unstructured":"Br\u00e1s IC, Outeiro TF. Alpha-synuclein: mechanisms of release and pathology progression in synucleinopathies. Cells. 2021;10(2):375. https:\/\/doi.org\/10.3390\/cells10020375.","journal-title":"Cells"},{"key":"38_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.arr.2019.01.012","volume":"50","author":"JY Vargas","year":"2019","unstructured":"Vargas JY, Grudina C, Zurzolo C. The prion-like spreading of \u03b1-synuclein: from in vitro to in vivo models of Parkinson\u2019s disease. Ageing Res Rev. 2019;50:89\u2013101. https:\/\/doi.org\/10.1016\/j.arr.2019.01.012.","journal-title":"Ageing Res Rev"},{"issue":"4","key":"38_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23747","volume":"72","author":"EC Freundt","year":"2012","unstructured":"Freundt EC, Maynard N, Clancy EK, Roy S, Bousset L, Sourigues Y, et al. Neuron-to-neuron transmission of \u03b1-synuclein fibrils through axonal transport. Ann Neurol. 2012;72(4):517\u201324. https:\/\/doi.org\/10.1002\/ana.23747.","journal-title":"Ann Neurol"},{"issue":"2","key":"38_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2285-7","volume":"11","author":"T Chakroun","year":"2020","unstructured":"Chakroun T, Evsyukov V, Nyk\u00e4nen NP, H\u00f6llerhage M, Schmidt A, Kamp F, et al. Alpha-synuclein fragments trigger distinct aggregation pathways. Cell Death Dis. 2020;11(2):84. https:\/\/doi.org\/10.1038\/s41419-020-2285-7.","journal-title":"Cell Death Dis"},{"issue":"4","key":"38_CR26","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-Suzukake","year":"2013","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, et al. Prion-like spreading of pathological \u03b1-synuclein in brain. Brain. 2013;136(4):1128\u201338. https:\/\/doi.org\/10.1093\/brain\/awt037.","journal-title":"Brain"},{"issue":"3","key":"38_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ana.24066","volume":"75","author":"A Recasens","year":"2014","unstructured":"Recasens A, Dehay B, Bov\u00e9 J, Carballo-Carbajal I, Dovero S, P\u00e9rez-Villalba A, et al. Lewy body extracts from Parkinson disease brains trigger \u03b1-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol. 2014;75(3):351\u201362. https:\/\/doi.org\/10.1002\/ana.24066.","journal-title":"Ann Neurol"},{"issue":"5","key":"38_CR28","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","volume":"149","author":"N Cremades","year":"2012","unstructured":"Cremades N, Cohen SIA, Deas E, Abramov AY, Chen AY, Orte A, et al. Direct observation of the interconversion of normal and toxic forms of \u03b1-Synuclein. Cell. 2012;149(5):1048\u201359. https:\/\/doi.org\/10.1016\/j.cell.2012.03.037.","journal-title":"Cell"},{"key":"38_CR29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143775","author":"A Singh","year":"2021","unstructured":"Singh A, Dawson TM, Kulkarni S. Neurodegenerative disorders and gut-brain interactions. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI143775.","journal-title":"J Clin Invest"},{"issue":"1","key":"38_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/2051-5960-1-2","volume":"1","author":"NP Visanji","year":"2013","unstructured":"Visanji NP, Brooks PL, Hazrati LN, Lang AE. The prion hypothesis in Parkinson\u2019s disease: Braak to the future. Acta Neuropathol Commun. 2013;1(1):2. https:\/\/doi.org\/10.1186\/2051-5960-1-2.","journal-title":"Acta Neuropathol Commun"},{"issue":"11","key":"38_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113573","volume":"19","author":"M Kujawska","year":"2018","unstructured":"Kujawska M, Jodynis-Liebert J. What is the evidence that Parkinson\u2019s Disease is a prion disorder, which originates in the gut? Int J Mol Sci. 2018;19(11):3573. https:\/\/doi.org\/10.3390\/ijms19113573.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"38_CR32","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/mds.28618","volume":"36","author":"DJ Surmeier","year":"2021","unstructured":"Surmeier DJ. Beyond just connectivity \u2014 neuronal activity drives \u03b1-Synuclein pathology. Mov Disord. 2021;36(7):1487\u20138. https:\/\/doi.org\/10.1002\/mds.28618.","journal-title":"Mov Disord"},{"issue":"8","key":"38_CR33","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/s41593-019-0457-5","volume":"22","author":"MX Henderson","year":"2019","unstructured":"Henderson MX, Cornblath EJ, Darwich A, Zhang B, Brown H, Gathagan RJ, et al. Spread of \u03b1-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis. Nat Neurosci. 2019;22(8):1248\u201357. https:\/\/doi.org\/10.1038\/s41593-019-0457-5.","journal-title":"Nat Neurosci"},{"issue":"46","key":"38_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc2487","volume":"6","author":"MT Henrich","year":"2020","unstructured":"Henrich MT, Geibl FF, Lakshminarasimhan H, Stegmann A, Giasson BI, Mao X, et al. Determinants of seeding and spreading of \u03b1-synuclein pathology in the brain. Sci Adv. 2020;6(46):eabc2487. https:\/\/doi.org\/10.1126\/sciadv.abc2487.","journal-title":"Sci Adv"},{"issue":"2","key":"38_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM. Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci. 2017;18(2):101\u201313. https:\/\/doi.org\/10.1038\/nrn.2016.178.","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"38_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Tredici KD, R\u00fcb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211. https:\/\/doi.org\/10.1016\/S0197-4580(02)00065-9.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"38_CR37","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak H, R\u00fcb U, Gai WP, Del Tredici K. Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm. 2003;110(5):517\u201336. https:\/\/doi.org\/10.1007\/s00702-002-0808-2.","journal-title":"J Neural Transm"},{"issue":"1","key":"38_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res. 2004;318(1):121\u201334. https:\/\/doi.org\/10.1007\/s00441-004-0956-9.","journal-title":"Cell Tissue Res"},{"issue":"10","key":"38_CR39","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager J, Andersen KB, Knudsen K, Skj\u00e6rb\u00e6k C, Fedorova TD, Okkels N, et al. Brain-first versus body-first Parkinson\u2019s disease: a multimodal imaging case-control study. Brain. 2020;143(10):3077\u201388. https:\/\/doi.org\/10.1093\/brain\/awaa238.","journal-title":"Brain"},{"issue":"5","key":"38_CR40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/neup.12691","volume":"40","author":"K Wakabayashi","year":"2020","unstructured":"Wakabayashi K. Where and how alpha-synuclein pathology spreads in Parkinson\u2019s disease. Neuropathology. 2020;40(5):415\u201325. https:\/\/doi.org\/10.1111\/neup.12691.","journal-title":"Neuropathology"},{"issue":"4","key":"38_CR41","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00401-013-1160-3","volume":"126","author":"NL Rey","year":"2013","unstructured":"Rey NL, Petit GH, Bousset L, Melki R, Brundin P. Transfer of human \u03b1-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol (Berl). 2013;126(4):555\u201373. https:\/\/doi.org\/10.1007\/s00401-013-1160-3.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"2","key":"38_CR42","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L. \u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med. 2012;2(2):a009399. https:\/\/doi.org\/10.1101\/cshperspect.a009399.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"38_CR43","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.str.2022.11.013","volume":"31","author":"Y Fan","year":"2023","unstructured":"Fan Y, Sun Y, Yu W, Tao Y, Xia W, Liu Y, et al. Conformational change of \u03b1-synuclein fibrils in cerebrospinal fluid from different clinical phases of Parkinson\u2019s disease. Structure. 2023;31(1):78-87.e5. https:\/\/doi.org\/10.1016\/j.str.2022.11.013.","journal-title":"Structure"},{"issue":"3","key":"38_CR44","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1074\/jbc.C100560200","volume":"277","author":"AB Manning-Bog","year":"2002","unstructured":"Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA. The herbicide Paraquat causes up-regulation and aggregation of \u03b1-synuclein in mice: PARAQUAT AND \u03b1-SYNUCLEIN*. J Biol Chem. 2002;277(3):1641\u20134. https:\/\/doi.org\/10.1074\/jbc.C100560200.","journal-title":"J Biol Chem"},{"issue":"2","key":"38_CR45","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/toxsci\/kfw117","volume":"153","author":"AB Cholanians","year":"2016","unstructured":"Cholanians AB, Phan AV, Ditzel EJ, Camenisch TD, Lau SS, Monks TJ. From the cover: arsenic induces accumulation of \u03b1-synuclein: implications for synucleinopathies and neurodegeneration. Toxicol Sci. 2016;153(2):271\u201381. https:\/\/doi.org\/10.1093\/toxsci\/kfw117.","journal-title":"Toxicol Sci"},{"issue":"42","key":"38_CR46","doi-asserted-by":"publisher","first-page":"E6506","DOI":"10.1073\/pnas.1606791113","volume":"113","author":"A Villar-Piqu\u00e9","year":"2016","unstructured":"Villar-Piqu\u00e9 A, Lopes da Fonseca T, Sant\u2019Anna R, Szeg\u00f6 \u00c9M, Fonseca-Ornelas L, Pinho R, et al. Environmental and genetic factors support the dissociation between \u03b1-synuclein aggregation and toxicity. Proc Natl Acad Sci U S A. 2016;113(42):E6506-15. https:\/\/doi.org\/10.1073\/pnas.1606791113.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"38_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105685","volume":"167","author":"SM Rocha","year":"2022","unstructured":"Rocha SM, Bantle CM, Aboellail T, Chatterjee D, Smeyne RJ, Tjalkens RB. Rotenone induces regionally distinct \u03b1-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl\/6 mice. Neurobiol Dis. 2022;167:105685. https:\/\/doi.org\/10.1016\/j.nbd.2022.105685.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"38_CR48","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024109","volume":"8","author":"RL Nussbaum","year":"2018","unstructured":"Nussbaum RL. Genetics of synucleinopathies. Cold Spring Harb Perspect Med. 2018;8(6):a024109. https:\/\/doi.org\/10.1101\/cshperspect.a024109.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"38_CR49","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/glia.24149","volume":"70","author":"P Garcia","year":"2022","unstructured":"Garcia P, J\u00fcrgens\u2010Wemheuer W, Uriarte Huarte O, Michelucci A, Masuch A, Brioschi S, et al. Neurodegeneration and neuroinflammation are linked, but independent of alpha\u2010synuclein inclusions, in a seeding\/spreading mouse model of Parkinson\u2019s disease. Glia. 2022;70(5):935\u201360. https:\/\/doi.org\/10.1002\/glia.24149.","journal-title":"Glia"},{"issue":"11","key":"38_CR50","doi-asserted-by":"publisher","first-page":"8996","DOI":"10.1007\/s12035-024-04124-5","volume":"61","author":"MR Fiorini","year":"2024","unstructured":"Fiorini MR, Dilliott AA, Thomas RA, Farhan SMK. Transcriptomics of human brain tissue in Parkinson\u2019s disease: a comparison of bulk and single-cell RNA sequencing. Mol Neurobiol. 2024;61(11):8996\u20139015. https:\/\/doi.org\/10.1007\/s12035-024-04124-5.","journal-title":"Mol Neurobiol"},{"issue":"6","key":"38_CR51","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1007\/s10753-025-02306-4","volume":"48","author":"Y Geng","year":"2025","unstructured":"Geng Y, Wang RY, Dong MY, Qian YL, Wang XH, Xia WW, et al. Integrated analysis of single-cell and transcriptome data reveals the role and regulatory mechanisms of neuroinflammation in Parkinson\u2019s disease. Inflammation. 2025;48(6):3986\u20134005. https:\/\/doi.org\/10.1007\/s10753-025-02306-4.","journal-title":"Inflammation"},{"issue":"1","key":"38_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62478-3","volume":"16","author":"M Ma","year":"2025","unstructured":"Ma M, Paryani F, Jakubiak K, Xia S, Antoku S, Kannan A, et al. The spatial landscape of glial pathology and T cell response in Parkinson\u2019s disease substantia nigra. Nat Commun. 2025;16(1):7146. https:\/\/doi.org\/10.1038\/s41467-025-62478-3.","journal-title":"Nat Commun"},{"key":"38_CR53","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.nbd.2015.03.003","volume":"85","author":"D Br\u00fcck","year":"2016","unstructured":"Br\u00fcck D, Wenning GK, Stefanova N, Fellner L. Glia and alpha-synuclein in neurodegeneration: a complex interaction. Neurobiol Dis. 2016;85:262\u201374. https:\/\/doi.org\/10.1016\/j.nbd.2015.03.003.","journal-title":"Neurobiol Dis"},{"issue":"12","key":"38_CR54","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/mds.25135","volume":"27","author":"JP Bolam","year":"2012","unstructured":"Bolam JP, Pissadaki EK. Living on the edge with too many mouths to feed: why dopamine neurons die. Mov Disord. 2012;27(12):1478\u201383. https:\/\/doi.org\/10.1002\/mds.25135.","journal-title":"Mov Disord"},{"key":"38_CR55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neures.2024.11.007","volume":"212","author":"M Nuermaimaiti","year":"2025","unstructured":"Nuermaimaiti M, Ishikawa K, Oyama G, Nonaka R, Shiga T, Jo T, et al. Human induced pluripotent stem cell-derived dopaminergic neurons release alpha-synuclein through neuronal activity. Neurosci Res. 2025;212:105\u201314. https:\/\/doi.org\/10.1016\/j.neures.2024.11.007.","journal-title":"Neurosci Res"},{"issue":"1","key":"38_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0241-0","volume":"13","author":"K Yamada","year":"2018","unstructured":"Yamada K, Iwatsubo T. Extracellular \u03b1-synuclein levels are regulated by neuronal activity. Mol Neurodegener. 2018;13(1):9. https:\/\/doi.org\/10.1186\/s13024-018-0241-0.","journal-title":"Mol Neurodegener"},{"key":"38_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.151514","volume":"758","author":"S Noda","year":"2025","unstructured":"Noda S, Sato S, Yamakado H, Takahashi R, Hattori N. Enhanced alpha-synuclein pathology and exacerbated motor dysfunction in alpha-synuclein transgenic mice with autophagy deficiency. Biochem Biophys Res Commun. 2025;758:151514. https:\/\/doi.org\/10.1016\/j.bbrc.2025.151514.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5688","key":"38_CR58","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant \u03b1-synuclein by chaperone-mediated autophagy. Science. 2004;305(5688):1292\u20135. https:\/\/doi.org\/10.1126\/science.1101738.","journal-title":"Science"},{"issue":"11","key":"38_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113143","volume":"10","author":"L Fellner","year":"2021","unstructured":"Fellner L, Gabassi E, Haybaeck J, Edenhofer F. Autophagy in \u03b1-synucleinopathies\u2014an overstrained system. Cells. 2021;10(11):3143. https:\/\/doi.org\/10.3390\/cells10113143.","journal-title":"Cells"},{"key":"38_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00457","volume":"13","author":"\u0160 Lehtonen","year":"2019","unstructured":"Lehtonen \u0160, Sonninen TM, Wojciechowski S, Goldsteins G, Koistinaho J. Dysfunction of cellular proteostasis in Parkinson\u2019s disease. Front Neurosci. 2019;13:457. https:\/\/doi.org\/10.3389\/fnins.2019.00457.","journal-title":"Front Neurosci"},{"issue":"1","key":"38_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56737-6","volume":"16","author":"J Gao","year":"2025","unstructured":"Gao J, Liu Y, Si C, Guo R, Hou S, Liu X, et al. Aspirin inhibits proteasomal degradation and promotes \u03b1-synuclein aggregate clearance through K63 ubiquitination. Nat Commun. 2025;16(1):1438. https:\/\/doi.org\/10.1038\/s41467-025-56737-6.","journal-title":"Nat Commun"},{"issue":"9","key":"38_CR62","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1172\/JCI127330","volume":"129","author":"RE Musgrove","year":"2019","unstructured":"Musgrove RE, Helwig M, Bae EJ, Aboutalebi H, Lee SJ, Ulusoy A, et al. Oxidative stress in vagal neurons promotes Parkinsonian pathology and intercellular \u03b1-synuclein transfer. J Clin Invest. 2019;129(9):3738\u201353. https:\/\/doi.org\/10.1172\/JCI127330.","journal-title":"J Clin Invest"},{"issue":"1","key":"38_CR63","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/15548627.2017.1395992","volume":"14","author":"G Minakaki","year":"2018","unstructured":"Minakaki G, Menges S, Kittel A, Emmanouilidou E, Schaeffner I, Barkovits K, et al. Autophagy inhibition promotes SNCA\/Alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype. Autophagy. 2018;14(1):98\u2013119. https:\/\/doi.org\/10.1080\/15548627.2017.1395992.","journal-title":"Autophagy"},{"issue":"3","key":"38_CR64","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","volume":"42","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJA, et al. Lysosomal dysfunction increases exosome-mediated Alpha-synuclein release and transmission. Neurobiol Dis. 2011;42(3):360\u20137. https:\/\/doi.org\/10.1016\/j.nbd.2011.01.029.","journal-title":"Neurobiol Dis"},{"issue":"10","key":"38_CR65","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1093\/hmg\/ddy075","volume":"27","author":"VE Papadopoulos","year":"2018","unstructured":"Papadopoulos VE, Nikolopoulou G, Antoniadou I, Karachaliou A, Arianoglou G, Emmanouilidou E, et al. Modulation of \u03b2-glucocerebrosidase increases \u03b1-synuclein secretion and exosome release in mouse models of Parkinson\u2019s disease. Hum Mol Genet. 2018;27(10):1696\u2013710. https:\/\/doi.org\/10.1093\/hmg\/ddy075.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"38_CR66","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1471-4159.2010.06695.x","volume":"113","author":"A Jang","year":"2010","unstructured":"Jang A, Lee HJ, Suk JE, Jung JW, Kim KP, Lee SJ. Non-classical exocytosis of \u03b1-synuclein is sensitive to folding states and promoted under stress conditions. J Neurochem. 2010;113(5):1263\u201374. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06695.x.","journal-title":"J Neurochem"},{"issue":"2","key":"38_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.108893","volume":"27","author":"T Abe","year":"2024","unstructured":"Abe T, Kuwahara T, Suenaga S, Sakurai M, Takatori S, Iwatsubo T. Lysosomal stress drives the release of pathogenic \u03b1-synuclein from macrophage lineage cells via the LRRK2-Rab10 pathway. iScience. 2024;27(2):108893. https:\/\/doi.org\/10.1016\/j.isci.2024.108893.","journal-title":"iScience"},{"key":"38_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.947191","author":"NJ Thorne","year":"2022","unstructured":"Thorne NJ, Tumbarello DA. The relationship of Alpha-synuclein to mitochondrial dynamics and quality control. Front Mol Neurosci. 2022. https:\/\/doi.org\/10.3389\/fnmol.2022.947191.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"38_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00733-y","volume":"10","author":"X Zhang","year":"2024","unstructured":"Zhang X, Ruan L, Wang H, Zhu J, Li T, Sun G, et al. Enhancing mitochondrial proteolysis alleviates Alpha-synuclein-mediated cellular toxicity. npj Parkinsons Dis. 2024;10(1):120. https:\/\/doi.org\/10.1038\/s41531-024-00733-y.","journal-title":"npj Parkinsons Dis"},{"issue":"12","key":"38_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11122466","volume":"11","author":"SJ Won","year":"2022","unstructured":"Won SJ, Fong R, Butler N, Sanchez J, Zhang Y, Wong C, et al. Neuronal oxidative stress promotes \u03b1-Synuclein aggregation in vivo. Antioxidants Basel. 2022;11(12):2466. https:\/\/doi.org\/10.3390\/antiox11122466.","journal-title":"Antioxidants Basel"},{"issue":"1","key":"38_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00842-8","volume":"10","author":"P La Vitola","year":"2024","unstructured":"La Vitola P, Szeg\u00f6 EM, Pinto-Costa R, Rollar A, Harbachova E, Schapira AH, et al. Mitochondrial oxidant stress promotes \u03b1-Synuclein aggregation and spreading in mice with mutated glucocerebrosidase. npj Parkinsons Dis. 2024;10(1):233. https:\/\/doi.org\/10.1038\/s41531-024-00842-8.","journal-title":"npj Parkinsons Dis"},{"issue":"6","key":"38_CR72","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/jnen\/nly024","volume":"77","author":"O Scudamore","year":"2018","unstructured":"Scudamore O, Ciossek T. Increased oxidative stress exacerbates \u03b1-Synuclein aggregation in vivo. J Neuropathol Exp Neurol. 2018;77(6):443\u201353. https:\/\/doi.org\/10.1093\/jnen\/nly024.","journal-title":"J Neuropathol Exp Neurol"},{"key":"38_CR73","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mcn.2013.01.004","volume":"54","author":"W Xiang","year":"2013","unstructured":"Xiang W, Schlachetzki JCM, Helling S, Bussmann JC, Berlinghof M, Sch\u00e4ffer TE, et al. Oxidative stress-induced posttranslational modifications of Alpha-synuclein: specific modification of Alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity. Mol Cell Neurosci. 2013;54:71\u201383. https:\/\/doi.org\/10.1016\/j.mcn.2013.01.004.","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"38_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-10705-8","volume":"15","author":"MD Byrne","year":"2025","unstructured":"Byrne MD, Petramfar P, Lee JK, Smeyne RJ. Templating of monomeric alpha-synuclein results in inflammation and SNpc dopamine neuron death in a genetic mouse model of induced synucleinopathy. Sci Rep. 2025;15(1):26537. https:\/\/doi.org\/10.1038\/s41598-025-10705-8.","journal-title":"Sci Rep"},{"issue":"1","key":"38_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47027-8","volume":"15","author":"TM Goralski","year":"2024","unstructured":"Goralski TM, Meyerdirk L, Breton L, Brasseur L, Kurgat K, DeWeerd D, et al. Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology. Nat Commun. 2024;15(1):2642. https:\/\/doi.org\/10.1038\/s41467-024-47027-8.","journal-title":"Nat Commun"},{"issue":"771","key":"38_CR76","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo1997","volume":"16","author":"B Zhu","year":"2024","unstructured":"Zhu B, Park JM, Coffey SR, Russo A, Hsu IU, Wang J, et al. Single-cell transcriptomic and proteomic analysis of Parkinson\u2019s disease brains. Sci Transl Med. 2024;16(771):eabo1997. https:\/\/doi.org\/10.1126\/scitranslmed.abo1997.","journal-title":"Sci Transl Med"},{"issue":"1","key":"38_CR77","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-015-1485-1","volume":"131","author":"T Uchihara","year":"2016","unstructured":"Uchihara T, Giasson BI. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol (Berl). 2016;131(1):49\u201373. https:\/\/doi.org\/10.1007\/s00401-015-1485-1.","journal-title":"Acta Neuropathol (Berl)"},{"key":"38_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1470171","volume":"17","author":"S Wu","year":"2024","unstructured":"Wu S, Schekman RW. Intercellular transmission of alpha-synuclein. Front Mol Neurosci. 2024;17:1470171. https:\/\/doi.org\/10.3389\/fnmol.2024.1470171.","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"38_CR79","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024380","volume":"7","author":"GK Tofaris","year":"2017","unstructured":"Tofaris GK, Goedert M, Spillantini MG. The transcellular propagation and intracellular trafficking of \u03b1-Synuclein. Cold Spring Harb Perspect Med. 2017;7(9):a024380. https:\/\/doi.org\/10.1101\/cshperspect.a024380.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"38_CR80","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1172\/JCI43366","volume":"121","author":"C Hansen","year":"2011","unstructured":"Hansen C, Angot E, Bergstr\u00f6m AL, Steiner JA, Pieri L, Paul G, et al. \u03b1-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest. 2011;121(2):715\u201325. https:\/\/doi.org\/10.1172\/JCI43366.","journal-title":"J Clin Invest"},{"key":"38_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00172","volume":"30","author":"M Delenclos","year":"2017","unstructured":"Delenclos M, Trendafilova T, Mahesh D, Baine AM, Moussaud S, Yan IK, et al. Investigation of endocytic pathways for the internalization of exosome-associated oligomeric alpha-synuclein. Front Neurosci. 2017;30:11. https:\/\/doi.org\/10.3389\/fnins.2017.00172.","journal-title":"Front Neurosci"},{"issue":"1","key":"38_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08720-5","volume":"7","author":"E Ihse","year":"2017","unstructured":"Ihse E, Yamakado H, van Wijk XM, Lawrence R, Esko JD, Masliah E. Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type. Sci Rep. 2017;7(1):9008. https:\/\/doi.org\/10.1038\/s41598-017-08720-5.","journal-title":"Sci Rep"},{"issue":"1","key":"38_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3575","volume":"4","author":"L Bousset","year":"2013","unstructured":"Bousset L, Pieri L, Ruiz-Arlandis G, Gath J, Jensen PH, Habenstein B, et al. Structural and functional characterization of two alpha-synuclein strains. Nat Commun. 2013;4(1):2575. https:\/\/doi.org\/10.1038\/ncomms3575.","journal-title":"Nat Commun"},{"issue":"19","key":"38_CR84","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.15252\/embj.201593411","volume":"35","author":"S Abounit","year":"2016","unstructured":"Abounit S, Bousset L, Loria F, Zhu S, de Chaumont F, Pieri L, et al. Tunneling nanotubes spread fibrillar \u03b1\u2010synuclein by intercellular trafficking of lysosomes. EMBO J. 2016;35(19):2120\u201338. https:\/\/doi.org\/10.15252\/embj.201593411.","journal-title":"EMBO J"},{"issue":"7","key":"38_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001287","volume":"19","author":"A Dilsizoglu Senol","year":"2021","unstructured":"Dilsizoglu Senol A, Samarani M, Syan S, Guardia CM, Nonaka T, Liv N, et al. \u03b1-Synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes. PLoS Biol. 2021;19(7):e3001287. https:\/\/doi.org\/10.1371\/journal.pbio.3001287.","journal-title":"PLoS Biol"},{"issue":"47","key":"38_CR86","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk KC, Song C, O\u2019Brien P, Stieber A, Branch JR, Brunden KR, et al. Exogenous \u03b1-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci. 2009;106(47):20051\u20136. https:\/\/doi.org\/10.1073\/pnas.0908005106.","journal-title":"Proc Natl Acad Sci"},{"issue":"45","key":"38_CR87","doi-asserted-by":"publisher","first-page":"34885","DOI":"10.1074\/jbc.M110.148460","volume":"285","author":"T Nonaka","year":"2010","unstructured":"Nonaka T, Watanabe ST, Iwatsubo T, Hasegawa M. Seeded aggregation and toxicity of \u03b1-synuclein and tau: cellular models of neurodegenerative diseases *. J Biol Chem. 2010;285(45):34885\u201398. https:\/\/doi.org\/10.1074\/jbc.M110.148460.","journal-title":"J Biol Chem"},{"issue":"1","key":"38_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0578-1","volume":"6","author":"C Masaracchia","year":"2018","unstructured":"Masaracchia C, Hnida M, Gerhardt E, Lopes da Fonseca T, Villar-Pique A, Branco T, et al. Membrane binding, internalization, and sorting of alpha-synuclein in the cell. Acta Neuropathol Commun. 2018;6(1):79. https:\/\/doi.org\/10.1186\/s40478-018-0578-1.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"38_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35811-8","volume":"9","author":"AC Hoffmann","year":"2019","unstructured":"Hoffmann AC, Minakaki G, Menges S, Salvi R, Savitskiy S, Kazman A, et al. Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose. Sci Rep. 2019;9(1):544. https:\/\/doi.org\/10.1038\/s41598-018-35811-8.","journal-title":"Sci Rep"},{"key":"38_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer KM, Kranich LR, Ruf WP, Cagsal-Getkin O, Winslow AR, Zhu L, et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener. 2012;7:42. https:\/\/doi.org\/10.1186\/1750-1326-7-42.","journal-title":"Mol Neurodegener"},{"key":"38_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2006.11.013","author":"A Klegeris","year":"2008","unstructured":"Klegeris A, Pelech S, Giasson BI, Maguire J, et al. \u03b1-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia. Neurobiol Aging. 2008. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.11.013.","journal-title":"Neurobiol Aging"},{"key":"38_CR92","doi-asserted-by":"publisher","DOI":"10.1042\/bj20150617","author":"A Gustot","year":"2015","unstructured":"Gustot A, Gallea JI, Sarroukh R, Celej MS, et al. Amyloid fibrils are the molecular trigger of inflammation in Parkinson\u2019s disease. Biochem J. 2015. https:\/\/doi.org\/10.1042\/bj20150617.","journal-title":"Biochem J"},{"issue":"1","key":"38_CR93","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, et al. Exogenous \u03b1-Synuclein fibrils induce Lewy Body pathology leading to synaptic dysfunction and neuron death. Neuron. 2011;72(1):57\u201371. https:\/\/doi.org\/10.1016\/j.neuron.2011.08.033.","journal-title":"Neuron"},{"issue":"6307","key":"38_CR94","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah3374","volume":"353","author":"X Mao","year":"2016","unstructured":"Mao X, Ou MT, Karuppagounder SS, Kam TI, Yin X, Xiong Y, et al. Pathological \u03b1-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science. 2016;353(6307):aah3374. https:\/\/doi.org\/10.1126\/science.aah3374.","journal-title":"Science"},{"issue":"12","key":"38_CR95","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"HJ Lee","year":"2010","unstructured":"Lee HJ, Suk JE, Patrick C, Bae EJ, Cho JH, Rho S, et al. Direct transfer of \u03b1-Synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem. 2010;285(12):9262\u201372. https:\/\/doi.org\/10.1074\/jbc.M109.081125.","journal-title":"J Biol Chem"},{"key":"38_CR96","doi-asserted-by":"publisher","unstructured":"Loria F, Vargas JY, Bousset L, Syan S, Salles A, Melki R, et al. \u03b1-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading. Acta Neuropathol (Berl). 2017;1\u201320. https:\/\/doi.org\/10.1007\/s00401-017-1746-2","DOI":"10.1007\/s00401-017-1746-2"},{"key":"38_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00413","volume":"12","author":"YH Koh","year":"2018","unstructured":"Koh YH, Tan LY, Ng SY. Patient-derived induced pluripotent stem cells and organoids for modeling alpha synuclein propagation in Parkinson\u2019s disease. Front Cell Neurosci. 2018;12:413. https:\/\/doi.org\/10.3389\/fncel.2018.00413.","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"38_CR98","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0093-25.2025","volume":"12","author":"OG Zetterdahl","year":"2025","unstructured":"Zetterdahl OG, Crowe JA, Reyhani S, G\u00fcra MA, Labastida-Botey O, Girard AS, et al. Generation of iPSC lines with tagged \u03b1-synuclein for visualization of endogenous protein in human cellular models of neurodegenerative disorders. eNeuro. 2025;12(6):ENEURO.0093\u201325.2025. https:\/\/doi.org\/10.1523\/ENEURO.0093-25.2025.","journal-title":"eNeuro"},{"key":"38_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.786835","volume":"12","author":"A Spathopoulou","year":"2022","unstructured":"Spathopoulou A, Edenhofer F, Fellner L. Targeting \u03b1-Synuclein in Parkinson\u2019s disease by induced pluripotent stem cell models. Front Neurol. 2022;12:786835. https:\/\/doi.org\/10.3389\/fneur.2021.786835.","journal-title":"Front Neurol"},{"key":"38_CR100","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1061470","volume":"2020","author":"X Hu","year":"2020","unstructured":"Hu X, Mao C, Fan L, Luo H, Hu Z, Zhang S, et al. Modeling Parkinson\u2019s disease using induced pluripotent stem cells. Stem Cells Int. 2020;2020:1061470. https:\/\/doi.org\/10.1155\/2020\/1061470.","journal-title":"Stem Cells Int"},{"issue":"3","key":"38_CR101","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.stemcr.2016.01.013","volume":"6","author":"HJR Fernandes","year":"2016","unstructured":"Fernandes HJR, Hartfield EM, Christian HC, Emmanoulidou E, Zheng Y, Booth H, et al. ER stress and autophagic perturbations lead to elevated extracellular \u03b1-Synuclein in GBA-N370S Parkinson\u2019s iPSC-derived dopamine neurons. Stem Cell Rep. 2016;6(3):342\u201356. https:\/\/doi.org\/10.1016\/j.stemcr.2016.01.013.","journal-title":"Stem Cell Rep"},{"issue":"2","key":"38_CR102","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.stemcr.2018.12.011","volume":"12","author":"A di Domenico","year":"2019","unstructured":"di Domenico A, Carola G, Calatayud C, Pons-Espinal M, Mu\u00f1oz JP, Richaud-Patin Y, et al. Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson\u2019s disease. Stem Cell Rep. 2019;12(2):213\u201329. https:\/\/doi.org\/10.1016\/j.stemcr.2018.12.011.","journal-title":"Stem Cell Rep"},{"issue":"1","key":"38_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09362-3","volume":"7","author":"W Haenseler","year":"2017","unstructured":"Haenseler W, Zambon F, Lee H, Vowles J, Rinaldi F, Duggal G, et al. Excess \u03b1-synuclein compromises phagocytosis in iPSC-derived macrophages. Sci Rep. 2017;7(1):9003. https:\/\/doi.org\/10.1038\/s41598-017-09362-3.","journal-title":"Sci Rep"},{"issue":"1","key":"38_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08076-5","volume":"12","author":"PV Rodrigues","year":"2022","unstructured":"Rodrigues PV, de Godoy JVP, Bosque BP, Amorim Neto DP, Tostes K, Palameta S, et al. Transcellular propagation of fibrillar \u03b1-synuclein from enteroendocrine to neuronal cells requires cell-to-cell contact and is Rab35-dependent. Sci Rep. 2022;12(1):4168. https:\/\/doi.org\/10.1038\/s41598-022-08076-5.","journal-title":"Sci Rep"},{"issue":"4","key":"38_CR105","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1093\/brain\/awae365","volume":"148","author":"E Frattini","year":"2024","unstructured":"Frattini E, Faustini G, Lopez G, Carsana EV, Tosi M, Trezzi I, et al. Lewy pathology formation in patient-derived GBA1 Parkinson\u2019s disease midbrain organoids. Brain. 2024;148(4):1242\u201357. https:\/\/doi.org\/10.1093\/brain\/awae365.","journal-title":"Brain"},{"issue":"9","key":"38_CR106","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.biocel.2008.01.017","volume":"40","author":"HJ Lee","year":"2008","unstructured":"Lee HJ, Suk JE, Bae EJ, Lee JH, Paik SR, Lee SJ. Assembly-dependent endocytosis and clearance of extracellular a-synuclein. Int J Biochem Cell Biol. 2008;40(9):1835\u201349. https:\/\/doi.org\/10.1016\/j.biocel.2008.01.017.","journal-title":"Int J Biochem Cell Biol"},{"issue":"29","key":"38_CR107","doi-asserted-by":"publisher","first-page":"27441","DOI":"10.1074\/jbc.M101318200","volume":"276","author":"JY Sung","year":"2001","unstructured":"Sung JY, Kim J, Paik SR, Park JH, Ahn YS, Chung KC. Induction of neuronal cell death by Rab5A-dependent endocytosis of \u03b1-synuclein*. J Biol Chem. 2001;276(29):27441\u20138. https:\/\/doi.org\/10.1074\/jbc.M101318200.","journal-title":"J Biol Chem"},{"issue":"9","key":"38_CR108","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1021\/pr0701512","volume":"6","author":"J Liu","year":"2007","unstructured":"Liu J, Zhou Y, Wang Y, Fong H, Murray TM, Zhang J. Identification of proteins involved in microglial endocytosis of \u03b1-synuclein. J Proteome Res. 2007;6(9):3614\u201327. https:\/\/doi.org\/10.1021\/pr0701512.","journal-title":"J Proteome Res"},{"issue":"33","key":"38_CR109","doi-asserted-by":"publisher","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","volume":"110","author":"BB Holmes","year":"2013","unstructured":"Holmes BB, DeVos SL, Kfoury N, Li M, Jacks R, Yanamandra K, et al. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc Natl Acad Sci U S A. 2013;110(33):E3138-47. https:\/\/doi.org\/10.1073\/pnas.1301440110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"38_CR110","doi-asserted-by":"publisher","first-page":"10865","DOI":"10.1073\/pnas.1918617117","volume":"117","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Xu Y, Lee J, Jarnik M, Wu X, Bonifacino JS, et al. A myosin-7B\u2013dependent endocytosis pathway mediates cellular entry of \u03b1-Synuclein fibrils and polycation-bearing cargos. Proc Natl Acad Sci U S A. 2020;117(20):10865\u201375. https:\/\/doi.org\/10.1073\/pnas.1918617117.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"38_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/cells12071083","volume":"12","author":"B Feller","year":"2023","unstructured":"Feller B, Fallon A, Luo W, Nguyen PT, Shlaifer I, Lee AK, et al. \u03b1-Synuclein preformed fibrils bind to \u03b2-neurexins and impair \u03b2-neurexin-mediated presynaptic organization. Cells. 2023;12(7):1083. https:\/\/doi.org\/10.3390\/cells12071083.","journal-title":"Cells"},{"issue":"13","key":"38_CR112","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E22-11-0496","volume":"34","author":"M Birol","year":"2023","unstructured":"Birol M, Mu\u00f1oz IID, Rhoades E. The C-terminus of \u03b1-Synuclein regulates its dynamic cellular internalization by neurexin 1\u03b2. Mol Biol Cell. 2023;34(13):br21. https:\/\/doi.org\/10.1091\/mbc.E22-11-0496.","journal-title":"Mol Biol Cell"},{"issue":"1","key":"38_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49016-3","volume":"15","author":"X Mao","year":"2024","unstructured":"Mao X, Gu H, Kim D, Kimura Y, Wang N, Xu E, et al. Aplp1 interacts with Lag3 to facilitate transmission of pathologic \u03b1-synuclein. Nat Commun. 2024;15(1):4663. https:\/\/doi.org\/10.1038\/s41467-024-49016-3.","journal-title":"Nat Commun"},{"issue":"1","key":"38_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00560-w","volume":"17","author":"K Chen","year":"2022","unstructured":"Chen K, Martens YA, Meneses A, Ryu DH, Lu W, Raulin AC, et al. LRP1 is a neuronal receptor for \u03b1-Synuclein uptake and spread. Mol Neurodegener. 2022;17(1):57. https:\/\/doi.org\/10.1186\/s13024-022-00560-w.","journal-title":"Mol Neurodegener"},{"issue":"6736","key":"38_CR115","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1126\/science.adp3645","volume":"387","author":"KM Wu","year":"2025","unstructured":"Wu KM, Xu QH, Liu YQ, Feng YW, Han SD, Zhang YR, et al. Neuronal FAM171A2 mediates \u03b1-Synuclein fibril uptake and drives Parkinson\u2019s disease. Science. 2025;387(6736):892\u2013900. https:\/\/doi.org\/10.1126\/science.adp3645.","journal-title":"Science"},{"issue":"7","key":"38_CR116","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/tra.12859","volume":"23","author":"P Hivare","year":"2022","unstructured":"Hivare P, Gadhavi J, Bhatia D, Gupta S. \u03b1-Synuclein fibrils explore actin-mediated macropinocytosis for cellular entry into model neuroblastoma neurons. Traffic. 2022;23(7):391\u2013410. https:\/\/doi.org\/10.1111\/tra.12859.","journal-title":"Traffic"},{"issue":"Pt 2","key":"38_CR117","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/brain\/awv346","volume":"139","author":"A Stuendl","year":"2016","unstructured":"Stuendl A, Kunadt M, Kruse N, Bartels C, Moebius W, Danzer KM, et al. Induction of \u03b1-Synuclein aggregate formation by CSF exosomes from patients with Parkinson\u2019s disease and dementia with Lewy bodies. Brain. 2016;139(Pt 2):481\u201394. https:\/\/doi.org\/10.1093\/brain\/awv346.","journal-title":"Brain"},{"key":"38_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0250-9","author":"M Mathieu","year":"2019","unstructured":"Mathieu M, Martin-Jaular L, Lavieu G, Th\u00e9ry C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019. https:\/\/doi.org\/10.1038\/s41556-018-0250-9.","journal-title":"Nat Cell Biol"},{"issue":"8","key":"38_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17081296","volume":"17","author":"I Prada","year":"2016","unstructured":"Prada I, Meldolesi J. Binding and fusion of extracellular vesicles to the plasma membrane of their cell targets. Int J Mol Sci. 2016;17(8):1296. https:\/\/doi.org\/10.3390\/ijms17081296.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"38_CR120","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1182\/blood-2011-02-338004","volume":"119","author":"A Montecalvo","year":"2012","unstructured":"Montecalvo A, Larregina AT, Shufesky WJ, Beer Stolz D, Sullivan MLG, Karlsson JM, et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood. 2012;119(3):756\u201366. https:\/\/doi.org\/10.1182\/blood-2011-02-338004.","journal-title":"Blood"},{"key":"38_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.125","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018. https:\/\/doi.org\/10.1038\/nrm.2017.125.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"38_CR122","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1021\/acsnano.9b10033","volume":"14","author":"BS Joshi","year":"2020","unstructured":"Joshi BS, de Beer MA, Giepmans BNG, Zuhorn IS. Endocytosis of extracellular vesicles and release of their cargo from endosomes. ACS Nano. 2020;14(4):4444\u201355. https:\/\/doi.org\/10.1021\/acsnano.9b10033.","journal-title":"ACS Nano"},{"issue":"1","key":"38_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22126-y","volume":"12","author":"E Bonsergent","year":"2021","unstructured":"Bonsergent E, Grisard E, Buchrieser J, Schwartz O, Th\u00e9ry C, Lavieu G. Quantitative characterization of extracellular vesicle uptake and content delivery within mammalian cells. Nat Commun. 2021;12(1):1864. https:\/\/doi.org\/10.1038\/s41467-021-22126-y.","journal-title":"Nat Commun"},{"issue":"3","key":"38_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111102","volume":"40","author":"A Bayati","year":"2022","unstructured":"Bayati A, Banks E, Han C, Luo W, Reintsch WE, Zorca CE, et al. Rapid macropinocytic transfer of \u03b1-synuclein to lysosomes. Cell Rep. 2022;40(3):111102. https:\/\/doi.org\/10.1016\/j.celrep.2022.111102.","journal-title":"Cell Rep"},{"issue":"11","key":"38_CR125","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1021\/acschemneuro.5c00236","volume":"16","author":"PME Ivey","year":"2025","unstructured":"Ivey PME, Guzman Sosa M, Salem A, Min S, Qi W, Scott AN, et al. Mechanisms of alpha-synuclein-seeded aggregation in neurons revealed by fluorescence lifetime imaging. ACS Chem Neurosci. 2025;16(11):2128\u201340. https:\/\/doi.org\/10.1021\/acschemneuro.5c00236.","journal-title":"ACS Chem Neurosci"},{"issue":"30","key":"38_CR126","doi-asserted-by":"publisher","first-page":"9322","DOI":"10.1073\/pnas.1500937112","volume":"112","author":"RP McGlinchey","year":"2015","unstructured":"McGlinchey RP, Lee JC. Cysteine cathepsins are essential in lysosomal degradation of \u03b1-synuclein. Proc Natl Acad Sci U S A. 2015;112(30):9322\u20137. https:\/\/doi.org\/10.1073\/pnas.1500937112.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"38_CR127","doi-asserted-by":"publisher","first-page":"7671","DOI":"10.1073\/pnas.1315346111","volume":"111","author":"AK Buell","year":"2014","unstructured":"Buell AK, Galvagnion C, Gaspar R, Sparr E, Vendruscolo M, Knowles TPJ, et al. Solution conditions determine the relative importance of nucleation and growth processes in \u03b1-synuclein aggregation. Proc Natl Acad Sci. 2014;111(21):7671\u20136. https:\/\/doi.org\/10.1073\/pnas.1315346111.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"38_CR128","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1471-4159.2006.03731.x","volume":"97","author":"KJ Ahn","year":"2006","unstructured":"Ahn KJ, Paik SR, Chung KC, Kim J. Amino acid sequence motifs and mechanistic features of the membrane translocation of \u03b1-synuclein. J Neurochem. 2006;97(1):265\u201379. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03731.x.","journal-title":"J Neurochem"},{"issue":"49","key":"38_CR129","doi-asserted-by":"publisher","first-page":"11835","DOI":"10.1523\/JNEUROSCI.0983-17.2017","volume":"37","author":"J Rostami","year":"2017","unstructured":"Rostami J, Holmqvist S, Lindstr\u00f6m V, Sigvardson J, Westermark GT, Ingelsson M, et al. Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes. J Neurosci. 2017;37(49):11835\u201353. https:\/\/doi.org\/10.1523\/JNEUROSCI.0983-17.2017.","journal-title":"J Neurosci"},{"issue":"2","key":"38_CR130","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s12035-021-02713-2","volume":"59","author":"E Vasili","year":"2022","unstructured":"Vasili E, Dominguez-Meijide A, Flores-Le\u00f3n M, Al-Azzani M, Kanellidi A, Melki R, et al. Endogenous levels of alpha-synuclein modulate seeding and aggregation in cultured cells. Mol Neurobiol. 2022;59(2):1273\u201384. https:\/\/doi.org\/10.1007\/s12035-021-02713-2.","journal-title":"Mol Neurobiol"},{"issue":"9","key":"38_CR131","doi-asserted-by":"publisher","first-page":"E1206","DOI":"10.1073\/pnas.1524128113","volume":"113","author":"M Iljina","year":"2016","unstructured":"Iljina M, Garcia GA, Horrocks MH, Tosatto L, Choi ML, Ganzinger KA, et al. Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading. Proc Natl Acad Sci U S A. 2016;113(9):E1206-15. https:\/\/doi.org\/10.1073\/pnas.1524128113.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"38_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10789-6","volume":"12","author":"T Ohgita","year":"2022","unstructured":"Ohgita T, Namba N, Kono H, Shimanouchi T, Saito H. Mechanisms of enhanced aggregation and fibril formation of Parkinson\u2019s disease-related variants of \u03b1-synuclein. Sci Rep. 2022;12(1):6770. https:\/\/doi.org\/10.1038\/s41598-022-10789-6.","journal-title":"Sci Rep"},{"issue":"43","key":"38_CR133","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh3457","volume":"9","author":"J Chlebowicz","year":"2023","unstructured":"Chlebowicz J, Russ W, Chen D, Vega A, Vernino S, White CL, et al. Saturation mutagenesis of \u03b1-synuclein reveals monomer fold that modulates aggregation. Sci Adv. 2023;9(43):eadh3457. https:\/\/doi.org\/10.1126\/sciadv.adh3457.","journal-title":"Sci Adv"},{"issue":"6","key":"38_CR134","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/mds.29401","volume":"38","author":"J Ueda","year":"2023","unstructured":"Ueda J, Uemura N, Ishimoto T, Taguchi T, Sawamura M, Nakanishi E, et al. Ca2+\u2013calmodulin\u2013calcineurin signaling modulates \u03b1-synuclein transmission. Mov Disord. 2023;38(6):1056\u201367. https:\/\/doi.org\/10.1002\/mds.29401.","journal-title":"Mov Disord"},{"issue":"25","key":"38_CR135","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","volume":"25","author":"HJ Lee","year":"2005","unstructured":"Lee HJ, Patel S, Lee SJ. Intravesicular localization and exocytosis of \u03b1-synuclein and its aggregates. J Neurosci. 2005;25(25):6016\u201324. https:\/\/doi.org\/10.1523\/JNEUROSCI.0692-05.2005.","journal-title":"J Neurosci"},{"issue":"24","key":"38_CR136","doi-asserted-by":"publisher","first-page":"17313","DOI":"10.1074\/jbc.M112.401174","volume":"288","author":"P Ejlerskov","year":"2013","unstructured":"Ejlerskov P, Rasmussen I, Nielsen TT, Bergstr\u00f6m AL, Tohyama Y, Jensen PH, et al. Tubulin polymerization-promoting protein (TPPP\/p25\u03b1) promotes unconventional secretion of \u03b1-synuclein through exophagy by impairing autophagosome-lysosome fusion. J Biol Chem. 2013;288(24):17313\u201335. https:\/\/doi.org\/10.1074\/jbc.M112.401174.","journal-title":"J Biol Chem"},{"issue":"1","key":"38_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-018-0012-7","volume":"4","author":"Y Xu","year":"2018","unstructured":"Xu Y, Cui L, Dibello A, Wang L, Lee J, Saidi L, et al. DNAJC5 facilitates USP19-dependent unconventional secretion of misfolded cytosolic proteins. Cell Discov. 2018;4(1):11. https:\/\/doi.org\/10.1038\/s41421-018-0012-7.","journal-title":"Cell Discov"},{"issue":"7","key":"38_CR138","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ncb3372","volume":"18","author":"JG Lee","year":"2016","unstructured":"Lee JG, Takahama S, Zhang G, Tomarev SI, Ye Y. Unconventional secretion of misfolded proteins promotes adaptation to proteasome dysfunction in mammalian cells. Nat Cell Biol. 2016;18(7):765\u201376. https:\/\/doi.org\/10.1038\/ncb3372.","journal-title":"Nat Cell Biol"},{"issue":"12","key":"38_CR139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029460","volume":"6","author":"T Hasegawa","year":"2011","unstructured":"Hasegawa T, Konno M, Baba T, Sugeno N, Kikuchi A, Kobayashi M, et al. The AAA-ATPase VPS4 regulates extracellular secretion and lysosomal targeting of \u03b1-synuclein. PLoS ONE. 2011;6(12):e29460. https:\/\/doi.org\/10.1371\/journal.pone.0029460.","journal-title":"PLoS ONE"},{"issue":"1","key":"38_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32625-1","volume":"13","author":"YX Xie","year":"2022","unstructured":"Xie YX, Naseri NN, Fels J, Kharel P, Na Y, Lane D, et al. Lysosomal exocytosis releases pathogenic \u03b1-synuclein species from neurons in synucleinopathy models. Nat Commun. 2022;13(1):4918. https:\/\/doi.org\/10.1038\/s41467-022-32625-1.","journal-title":"Nat Commun"},{"issue":"46","key":"38_CR141","doi-asserted-by":"publisher","first-page":"15281","DOI":"10.1523\/JNEUROSCI.1629-14.2014","volume":"34","author":"T Tsunemi","year":"2014","unstructured":"Tsunemi T, Hamada K, Krainc D. ATP13A2\/PARK9 regulates secretion of exosomes and \u03b1-synuclein. J Neurosci. 2014;34(46):15281\u20137. https:\/\/doi.org\/10.1523\/JNEUROSCI.1629-14.2014.","journal-title":"J Neurosci"},{"issue":"20","key":"38_CR142","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, et al. Cell-produced \u03b1-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci. 2010;30(20):6838\u201351. https:\/\/doi.org\/10.1523\/JNEUROSCI.5699-09.2010.","journal-title":"J Neurosci"},{"issue":"5","key":"38_CR143","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/brain\/awaa090","volume":"143","author":"M Guo","year":"2020","unstructured":"Guo M, Wang J, Zhao Y, Feng Y, Han S, Dong Q, et al. Microglial exosomes facilitate \u03b1-synuclein transmission in Parkinson\u2019s disease. Brain. 2020;143(5):1476\u201397. https:\/\/doi.org\/10.1093\/brain\/awaa090.","journal-title":"Brain"},{"issue":"2","key":"38_CR144","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14387","volume":"24","author":"S Cohen\u2010Adiv","year":"2024","unstructured":"Cohen\u2010Adiv S, Amer\u2010Sarsour F, Berdichevsky Y, Boxer E, Goldstein O, Gana\u2010Weisz M, et al. TMEM16F regulates pathologic \u03b1\u2010synuclein secretion and spread in cellular and mouse models of Parkinson\u2019s disease. Aging Cell. 2024;24(2):e14387. https:\/\/doi.org\/10.1111\/acel.14387.","journal-title":"Aging Cell"},{"issue":"8","key":"38_CR145","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/glia.23631","volume":"67","author":"EF D\u00edaz","year":"2019","unstructured":"D\u00edaz EF, Labra VC, Alvear TF, Mellado LA, Inostroza CA, Oyarz\u00fan JE, et al. Connexin 43 hemichannels and pannexin-1 channels contribute to the \u03b1-synuclein-induced dysfunction and death of astrocytes. Glia. 2019;67(8):1598\u2013619. https:\/\/doi.org\/10.1002\/glia.23631.","journal-title":"Glia"},{"issue":"1","key":"38_CR146","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00401-019-02007-x","volume":"138","author":"JF Reyes","year":"2019","unstructured":"Reyes JF, Sackmann C, Hoffmann A, Svenningsson P, Winkler J, Ingelsson M, et al. Binding of \u03b1-synuclein oligomers to Cx32 facilitates protein uptake and transfer in neurons and oligodendrocytes. Acta Neuropathol. 2019;138(1):23\u201347. https:\/\/doi.org\/10.1007\/s00401-019-02007-x.","journal-title":"Acta Neuropathol"},{"key":"38_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/srep42984","volume":"7","author":"BV Dieriks","year":"2017","unstructured":"Dieriks BV, Park TIH, Fourie C, Faull RLM, Dragunow M, Curtis MA. \u03b1-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson\u2019s disease patients. Sci Rep. 2017;7:42984. https:\/\/doi.org\/10.1038\/srep42984.","journal-title":"Sci Rep"},{"issue":"20","key":"38_CR148","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1016\/j.cell.2021.09.007","volume":"184","author":"H Scheiblich","year":"2021","unstructured":"Scheiblich H, Dansokho C, Mercan D, Schmidt SV, Bousset L, Wischhof L, et al. Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes. Cell. 2021;184(20):5089-5106.e21. https:\/\/doi.org\/10.1016\/j.cell.2021.09.007.","journal-title":"Cell"},{"issue":"5","key":"38_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05835-8","volume":"14","author":"R Chakraborty","year":"2023","unstructured":"Chakraborty R, Nonaka T, Hasegawa M, Zurzolo C. Tunnelling nanotubes between neuronal and microglial cells allow bi-directional transfer of \u03b1-Synuclein and mitochondria. Cell Death Dis. 2023;14(5):329. https:\/\/doi.org\/10.1038\/s41419-023-05835-8.","journal-title":"Cell Death Dis"},{"issue":"38","key":"38_CR150","doi-asserted-by":"publisher","first-page":"8211","DOI":"10.1523\/JNEUROSCI.1134-18.2018","volume":"38","author":"B Wang","year":"2018","unstructured":"Wang B, Underwood R, Kamath A, Britain C, McFerrin MB, McLean PJ, et al. 14-3-3 proteins reduce cell-to-cell transfer and propagation of pathogenic \u03b1-Synuclein. J Neurosci. 2018;38(38):8211\u201332. https:\/\/doi.org\/10.1523\/JNEUROSCI.1134-18.2018.","journal-title":"J Neurosci"},{"issue":"1","key":"38_CR151","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ana.410430109","volume":"43","author":"I Zerr","year":"1998","unstructured":"Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, et al. Detection of 14\u20133-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol. 1998;43(1):32\u201340. https:\/\/doi.org\/10.1002\/ana.410430109.","journal-title":"Ann Neurol"},{"issue":"2","key":"38_CR152","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.stemcr.2018.12.007","volume":"12","author":"S Gribaudo","year":"2019","unstructured":"Gribaudo S, Tixador P, Bousset L, Fenyi A, Lino P, Melki R, et al. Propagation of \u03b1-Synuclein strains within human reconstructed neuronal network. Stem Cell Rep. 2019;12(2):230\u201344. https:\/\/doi.org\/10.1016\/j.stemcr.2018.12.007.","journal-title":"Stem Cell Rep"},{"issue":"1","key":"38_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-00936-x","volume":"11","author":"R Vroman","year":"2025","unstructured":"Vroman R, de Lichtervelde L, Singh Dolt K, Robertson G, Kriek M, Barbato M, et al. A high-fidelity microfluidic platform reveals retrograde propagation as the main mechanism of \u03b1-Synuclein spread in human neurons. npj Park Dis. 2025;11(1):80. https:\/\/doi.org\/10.1038\/s41531-025-00936-x.","journal-title":"npj Park Dis"},{"issue":"3","key":"38_CR154","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40478-015-0198-y","volume":"24","author":"A Ulusoy","year":"2015","unstructured":"Ulusoy A, Musgrove RE, Rusconi R, Klinkenberg M, Helwig M, Schneider A, et al. Neuron-to-neuron \u03b1-synuclein propagation in vivo is independent of neuronal injury. Acta Neuropathol Commun. 2015;24(3):13. https:\/\/doi.org\/10.1186\/s40478-015-0198-y.","journal-title":"Acta Neuropathol Commun"},{"issue":"10","key":"38_CR155","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-04915-4","volume":"80","author":"J Courte","year":"2023","unstructured":"Courte J, Le NA, Pan T, Bousset L, Melki R, Villard C, et al. Synapses do not facilitate prion-like transfer of alpha-synuclein: a quantitative study in reconstructed unidirectional neural networks. Cell Mol Life Sci. 2023;80(10):284. https:\/\/doi.org\/10.1007\/s00018-023-04915-4.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"38_CR156","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00401-016-1538-0","volume":"131","author":"M Brahic","year":"2016","unstructured":"Brahic M, Bousset L, Bieri G, Melki R, Gitler AD. Axonal transport and secretion of fibrillar forms of \u03b1-synuclein, A\u03b242 peptide and HTTExon 1. Acta Neuropathol (Berl). 2016;131(4):539\u201348. https:\/\/doi.org\/10.1007\/s00401-016-1538-0.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"6","key":"38_CR157","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bj\u00f6rklund T, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol (Berl). 2014;128(6):805\u201320. https:\/\/doi.org\/10.1007\/s00401-014-1343-6.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"1","key":"38_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00618-6","volume":"10","author":"NC Prymaczok","year":"2024","unstructured":"Prymaczok NC, De Francesco PN, Mazzetti S, Humbert-Claude M, Tenenbaum L, Cappelletti G, et al. Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson\u2019s disease. Npj Park Dis. 2024;10(1):10. https:\/\/doi.org\/10.1038\/s41531-023-00618-6.","journal-title":"Npj Park Dis"},{"issue":"36","key":"38_CR159","doi-asserted-by":"publisher","first-page":"13910","DOI":"10.1074\/jbc.RA118.001862","volume":"293","author":"M Terada","year":"2018","unstructured":"Terada M, Suzuki G, Nonaka T, Kametani F, Tamaoka A, Hasegawa M. The effect of truncation on prion-like properties of \u03b1-synuclein. J Biol Chem. 2018;293(36):13910\u201320. https:\/\/doi.org\/10.1074\/jbc.RA118.001862.","journal-title":"J Biol Chem"},{"issue":"32","key":"38_CR160","doi-asserted-by":"publisher","first-page":"13482","DOI":"10.1074\/jbc.M117.780296","volume":"292","author":"RJ Karpowicz","year":"2017","unstructured":"Karpowicz RJ, Haney CM, Mihaila TS, Sandler RM, Petersson EJ, Lee VMY. Selective imaging of internalized proteopathic \u03b1-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies. J Biol Chem. 2017;292(32):13482\u201397. https:\/\/doi.org\/10.1074\/jbc.M117.780296.","journal-title":"J Biol Chem"},{"issue":"5","key":"38_CR161","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.molcel.2015.07.012","volume":"59","author":"X Gao","year":"2015","unstructured":"Gao X, Carroni M, Nussbaum-Krammer C, Mogk A, Nillegoda NB, Szlachcic A, et al. Human Hsp70 disaggregase reverses Parkinson\u2019s-linked \u03b1-synuclein amyloid fibrils. Mol Cell. 2015;59(5):781\u201393. https:\/\/doi.org\/10.1016\/j.molcel.2015.07.012.","journal-title":"Mol Cell"},{"issue":"1","key":"38_CR162","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-11-125","volume":"11","author":"VL Anderson","year":"2011","unstructured":"Anderson VL, Webb WW. Transmission electron microscopy characterization of fluorescently labelled amyloid \u03b2 1-40 and \u03b1-synuclein aggregates. BMC Biotechnol. 2011;11(1):125. https:\/\/doi.org\/10.1186\/1472-6750-11-125.","journal-title":"BMC Biotechnol"},{"issue":"20","key":"38_CR163","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.1111\/febs.17244","volume":"291","author":"M Ziaunys","year":"2024","unstructured":"Ziaunys M, Sulskis D, Veiveris D, Kopustas A, Snieckute R, Mikalauskaite K, et al. Liquid\u2013liquid phase separation of alpha-synuclein increases the structural variability of fibrils formed during amyloid aggregation. FEBS J. 2024;291(20):4522\u201338. https:\/\/doi.org\/10.1111\/febs.17244.","journal-title":"FEBS J"},{"key":"38_CR164","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0007-20.2020","author":"A Caputo","year":"2020","unstructured":"Caputo A, Liang Y, Raabe TD, Lo A, Horvath M, Zhang B, et al. Snca-GFP knock-in mice reflect patterns of endogenous expression and pathological seeding. eNeuro. 2020. https:\/\/doi.org\/10.1523\/ENEURO.0007-20.2020.","journal-title":"eNeuro"},{"issue":"10","key":"38_CR165","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.bbapap.2016.07.007","volume":"1864","author":"M Mu\u010dibabi\u0107","year":"2016","unstructured":"Mu\u010dibabi\u0107 M, Apetri MM, Canters GW, Aartsma TJ. The effect of fluorescent labeling on \u03b1-synuclein fibril morphology. Biochim Biophys Acta Proteins Proteomics. 2016;1864(10):1419\u201327. https:\/\/doi.org\/10.1016\/j.bbapap.2016.07.007.","journal-title":"Biochim Biophys Acta Proteins Proteomics"},{"issue":"18","key":"38_CR166","doi-asserted-by":"publisher","first-page":"8270","DOI":"10.1039\/D2NR05487F","volume":"15","author":"S Jadavi","year":"2023","unstructured":"Jadavi S, Dante S, Civiero L, Sandre M, Bubacco L, Tosatto L, et al. Fluorescence labeling methods influence the aggregation process of \u03b1-syn in vitro differently. Nanoscale. 2023;15(18):8270\u20137. https:\/\/doi.org\/10.1039\/D2NR05487F.","journal-title":"Nanoscale"},{"issue":"4","key":"38_CR167","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00401-022-02476-7","volume":"144","author":"SAM Holec","year":"2022","unstructured":"Holec SAM, Lee J, Oehler A, Ooi FK, Mordes DA, Olson SH, et al. Multiple system atrophy prions transmit neurological disease to mice expressing wild-type human \u03b1-synuclein. Acta Neuropathol (Berl). 2022;144(4):677\u201390. https:\/\/doi.org\/10.1007\/s00401-022-02476-7.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"1","key":"38_CR168","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03948-y","volume":"5","author":"B Frieg","year":"2022","unstructured":"Frieg B, Geraets JA, Stroh\u00e4ker T, Dienemann C, Mavroeidi P, Jung BC, et al. Quaternary structure of patient-homogenate amplified \u03b1-synuclein fibrils modulates seeding of endogenous \u03b1-synuclein. Commun Biol. 2022;5(1):1040. https:\/\/doi.org\/10.1038\/s42003-022-03948-y.","journal-title":"Commun Biol"},{"issue":"1","key":"38_CR169","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46832-5","volume":"15","author":"DD Dhavale","year":"2024","unstructured":"Dhavale DD, Barclay AM, Borcik CG, Basore K, Berthold DA, Gordon IR, et al. Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue. Nat Commun. 2024;15(1):2750. https:\/\/doi.org\/10.1038\/s41467-024-46832-5.","journal-title":"Nat Commun"},{"issue":"5","key":"38_CR170","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00401-023-02550-8","volume":"145","author":"Y Yang","year":"2023","unstructured":"Yang Y, Garringer HJ, Shi Y, L\u00f6vestam S, Peak-Chew S, Zhang X, et al. New SNCA mutation and structures of \u03b1-synuclein filaments from juvenile-onset synucleinopathy. Acta Neuropathol (Berl). 2023;145(5):561\u201372. https:\/\/doi.org\/10.1007\/s00401-023-02550-8.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"7825","key":"38_CR171","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser M, Shi Y, Tarutani A, Kametani F, Murzin AG, Ghetti B, et al. Structures of \u03b1-synuclein filaments from multiple system atrophy. Nature. 2020;585(7825):464\u20139. https:\/\/doi.org\/10.1038\/s41586-020-2317-6.","journal-title":"Nature"},{"issue":"7933","key":"38_CR172","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","volume":"610","author":"Y Yang","year":"2022","unstructured":"Yang Y, Shi Y, Schweighauser M, Zhang X, Kotecha A, Murzin AG, et al. Structures of \u03b1-synuclein filaments from human brains with Lewy pathology. Nature. 2022;610(7933):791\u20135. https:\/\/doi.org\/10.1038\/s41586-022-05319-3.","journal-title":"Nature"},{"issue":"10","key":"38_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109189","volume":"35","author":"E Kara","year":"2021","unstructured":"Kara E, Crimi A, Wiedmer A, Emmenegger M, Manzoni C, Bandres-Ciga S, et al. An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of \u03b1-synuclein. Cell Rep. 2021;35(10):109189. https:\/\/doi.org\/10.1016\/j.celrep.2021.109189.","journal-title":"Cell Rep"},{"issue":"5","key":"38_CR174","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1021\/acs.jmedchem.9b00797","volume":"63","author":"DG Brown","year":"2020","unstructured":"Brown DG, Wobst HJ. Opportunities and challenges in phenotypic screening for neurodegenerative disease research. J Med Chem. 2020;63(5):1823\u201340. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00797.","journal-title":"J Med Chem"},{"issue":"6","key":"38_CR175","doi-asserted-by":"publisher","first-page":"899","DOI":"10.4252\/wjsc.v7.i6.899","volume":"7","author":"AB Bradford","year":"2015","unstructured":"Bradford AB, McNutt PM. Importance of being Nernst: synaptic activity and functional relevance in stem cell-derived neurons. World J Stem Cells. 2015;7(6):899\u2013921. https:\/\/doi.org\/10.4252\/wjsc.v7.i6.899.","journal-title":"World J Stem Cells"},{"issue":"4","key":"38_CR176","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1038\/s41380-023-01990-8","volume":"28","author":"Y Hong","year":"2023","unstructured":"Hong Y, Yang Q, Song H, Ming GL. Opportunities and limitations for studying neuropsychiatric disorders using patient-derived induced pluripotent stem cells. Mol Psychiatry. 2023;28(4):1430\u20139. https:\/\/doi.org\/10.1038\/s41380-023-01990-8.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"38_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106285","volume":"26","author":"W Lin","year":"2023","unstructured":"Lin W, Shiomoto S, Yamada S, Watanabe H, Kawashima Y, Eguchi Y, et al. Dendritic spine formation and synapse maturation in transcription factor-induced human iPSC-derived neurons. iScience. 2023;26(4):106285. https:\/\/doi.org\/10.1016\/j.isci.2023.106285.","journal-title":"iScience"},{"issue":"3","key":"38_CR178","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.neuron.2012.11.033","volume":"77","author":"DA MacLeod","year":"2013","unstructured":"MacLeod DA, Rhinn H, Kuwahara T, Zolin A, Di Paolo G, McCabe BD, et al. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson\u2019s disease risk. Neuron. 2013;77(3):425\u201339. https:\/\/doi.org\/10.1016\/j.neuron.2012.11.033.","journal-title":"Neuron"},{"issue":"12","key":"38_CR179","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.cell.2022.05.008","volume":"185","author":"E Hallacli","year":"2022","unstructured":"Hallacli E, Kayatekin C, Nazeen S, Wang XH, Sheinkopf Z, Sathyakumar S, et al. The Parkinson\u2019s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability. Cell. 2022;185(12):2035-2056.e33. https:\/\/doi.org\/10.1016\/j.cell.2022.05.008.","journal-title":"Cell"},{"issue":"2","key":"38_CR180","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009359","volume":"17","author":"S Sarkar","year":"2021","unstructured":"Sarkar S, Olsen AL, Sygnecka K, Lohr KM, Feany MB. \u03b1-synuclein impairs autophagosome maturation through abnormal actin stabilization. PLOS Genet. 2021;17(2):e1009359. https:\/\/doi.org\/10.1371\/journal.pgen.1009359.","journal-title":"PLOS Genet"},{"issue":"2","key":"38_CR181","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab049","volume":"3","author":"JC Bridi","year":"2021","unstructured":"Bridi JC, Bereczki E, Smith SK, Po\u00e7as GM, Kottler B, Domingos PM, et al. Presynaptic accumulation of \u03b1-synuclein causes synaptopathy and progressive neurodegeneration in Drosophila. Brain Commun. 2021;3(2):fcab049. https:\/\/doi.org\/10.1093\/braincomms\/fcab049.","journal-title":"Brain Commun"},{"issue":"4","key":"38_CR182","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/hmg\/ddu521","volume":"24","author":"C Breda","year":"2015","unstructured":"Breda C, Nugent ML, Estranero JG, Kyriacou CP, Outeiro TF, Steinert JR, et al. Rab11 modulates \u03b1-synuclein-mediated defects in synaptic transmission and behaviour. Hum Mol Genet. 2015;24(4):1077\u201391. https:\/\/doi.org\/10.1093\/hmg\/ddu521.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"38_CR183","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/JPD-171258","volume":"8","author":"JF Cooper","year":"2018","unstructured":"Cooper JF, Van Raamsdonk JM. Modeling Parkinson\u2019s disease in <i_tag>C. elegans<\/i_tag>. J Park Dis. 2018;8(1):17\u201332. https:\/\/doi.org\/10.3233\/JPD-171258.","journal-title":"J Park Dis"},{"key":"38_CR184","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.gde.2017.02.011","volume":"44","author":"BA Martinez","year":"2017","unstructured":"Martinez BA, Caldwell KA, Caldwell GA. C. <i_tag>elegans<\/i_tag> as a model system to accelerate discovery for Parkinson disease. Curr Opin Genet Dev Mol Gen Bases Dis. 2017;44:102\u20139. https:\/\/doi.org\/10.1016\/j.gde.2017.02.011.","journal-title":"Curr Opin Genet Dev Mol Gen Bases Dis"},{"key":"38_CR185","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2017.00077","author":"M Maulik","year":"2017","unstructured":"Maulik M, Mitra S, Bult-Ito A, Taylor BE, Vayndorf EM. Behavioral phenotyping and pathological indicators of Parkinson\u2019s disease in C. elegans models. Front Genet. 2017. https:\/\/doi.org\/10.3389\/fgene.2017.00077.","journal-title":"Front Genet"},{"issue":"3","key":"38_CR186","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3390\/cells10030579","volume":"10","author":"M Vos","year":"2021","unstructured":"Vos M, Klein C. The importance of drosophila melanogaster research to uncover cellular pathways underlying Parkinson\u2019s disease. Cells. 2021;10(3):579. https:\/\/doi.org\/10.3390\/cells10030579.","journal-title":"Cells"},{"issue":"1","key":"38_CR187","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.nbd.2010.04.002","volume":"40","author":"C Yao","year":"2010","unstructured":"Yao C, El Khoury R, Wang W, Byrd TA, Pehek EA, Thacker C, et al. LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a <i_tag>Caenorhabditis elegans<\/i_tag> model of Parkinson\u2019s disease. Neurobiol Dis. 2010;40(1):73\u201381. https:\/\/doi.org\/10.1016\/j.nbd.2010.04.002.","journal-title":"Neurobiol Dis"},{"issue":"6776","key":"38_CR188","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/35006074","volume":"404","author":"MB Feany","year":"2000","unstructured":"Feany MB, Bender WW. A drosophila model of Parkinson\u2019s disease. Nature. 2000;404(6776):394\u20138. https:\/\/doi.org\/10.1038\/35006074.","journal-title":"Nature"},{"issue":"9","key":"38_CR189","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.050858","volume":"17","author":"K Bankapalli","year":"2024","unstructured":"Bankapalli K, Thomas RE, Vincow ES, Milstein G, Fisher LV, Pallanck LJ. A Drosophila model for mechanistic investigation of tau protein spread. Dis Model Mech. 2024;17(9):dmm050858. https:\/\/doi.org\/10.1242\/dmm.050858.","journal-title":"Dis Model Mech"},{"key":"38_CR190","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07383-6","volume":"8","author":"T Tyson","year":"2017","unstructured":"Tyson T, Senchuk M, Cooper JF, George S, Van Raamsdonk JM, Brundin P. Novel animal model defines genetic contributions for neuron-to-neuron transfer of \u03b1-synuclein. Sci Rep. 2017;8:7506. https:\/\/doi.org\/10.1038\/s41598-017-07383-6.","journal-title":"Sci Rep"},{"key":"38_CR191","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202201366","author":"M Chen","year":"2022","unstructured":"Chen M, Vincent J, Ezeanii A, Wakade S, Yerigenahally S, Mor DE. Heparan sulfate proteoglycans mediate prion-like \u03b1-synuclein toxicity in Parkinson\u2019s in vivo models. Life Sci Alliance. 2022. https:\/\/doi.org\/10.26508\/lsa.202201366.","journal-title":"Life Sci Alliance"},{"issue":"12","key":"38_CR192","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041644","volume":"15","author":"VL Dawson","year":"2025","unstructured":"Dawson VL, Dawson TM. Animal models of Parkinson\u2019s disease. Cold Spring Harb Perspect Med. 2025;15(12):a041644. https:\/\/doi.org\/10.1101\/cshperspect.a041644.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"38_CR193","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.79418","volume":"11","author":"A Beauchamp","year":"2022","unstructured":"Beauchamp A, Yee Y, Darwin BC, Raznahan A, Mars RB, Lerch JP. Whole-brain comparison of rodent and human brains using spatial transcriptomics. Elife. 2022;11:e79418. https:\/\/doi.org\/10.7554\/eLife.79418.","journal-title":"Elife"},{"issue":"1","key":"38_CR194","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-01026-0","volume":"8","author":"AJ Schaser","year":"2020","unstructured":"Schaser AJ, Stackhouse TL, Weston LJ, Kerstein PC, Osterberg VR, L\u00f3pez CS, et al. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy. Acta Neuropathol Commun. 2020;8(1):150. https:\/\/doi.org\/10.1186\/s40478-020-01026-0.","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"38_CR195","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","volume":"23","author":"C Challis","year":"2020","unstructured":"Challis C, Hori A, Sampson TR, Yoo BB, Challis RC, Hamilton AM, et al. Gut-seeded \u03b1-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci. 2020;23(3):327\u201336. https:\/\/doi.org\/10.1038\/s41593-020-0589-7.","journal-title":"Nat Neurosci"},{"issue":"2","key":"38_CR196","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13036","volume":"32","author":"F Sun","year":"2022","unstructured":"Sun F, Salinas AG, Filser S, Blumenstock S, Medina-Luque J, Herms J, et al. Impact of \u03b1-synuclein spreading on the nigrostriatal dopaminergic pathway depends on the onset of the pathology. Brain Pathol. 2022;32(2):e13036. https:\/\/doi.org\/10.1111\/bpa.13036.","journal-title":"Brain Pathol"},{"issue":"7","key":"38_CR197","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201302475","volume":"5","author":"A Ulusoy","year":"2013","unstructured":"Ulusoy A, Rusconi R, P\u00e9rez\u2010Revuelta BI, Musgrove RE, Helwig M, Winzen\u2010Reichert B, et al. Caudo\u2010rostral brain spreading of \u03b1\u2010synuclein through vagal connections. EMBO Mol Med. 2013;5(7):EMMM201302475. https:\/\/doi.org\/10.1002\/emmm.201302475.","journal-title":"EMBO Mol Med"},{"issue":"4","key":"38_CR198","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, et al. Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron. 2019;103(4):627-641.e7. https:\/\/doi.org\/10.1016\/j.neuron.2019.05.035.","journal-title":"Neuron"},{"issue":"1","key":"38_CR199","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0257-5","volume":"13","author":"N Uemura","year":"2018","unstructured":"Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R. Inoculation of \u03b1-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener. 2018;13(1):21. https:\/\/doi.org\/10.1186\/s13024-018-0257-5.","journal-title":"Mol Neurodegener"},{"issue":"8","key":"38_CR200","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/jnr.22331","volume":"88","author":"DR Graham","year":"2010","unstructured":"Graham DR, Sidhu A. Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior. J Neurosci Res. 2010;88(8):1777\u201383. https:\/\/doi.org\/10.1002\/jnr.22331.","journal-title":"J Neurosci Res"},{"issue":"8","key":"38_CR201","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070274","volume":"8","author":"KL Paumier","year":"2013","unstructured":"Paumier KL, Rizzo SJS, Berger Z, Chen Y, Gonzales C, Kaftan E, et al. Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson\u2019s disease. PLoS One. 2013;8(8):e70274. https:\/\/doi.org\/10.1371\/journal.pone.0070274.","journal-title":"PLoS One"},{"issue":"2","key":"38_CR202","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3233\/JAD-200983","volume":"79","author":"L Gabrielyan","year":"2021","unstructured":"Gabrielyan L, Liang H, Minalyan A, Hatami A, John V, Wang L. Behavioral deficits and brain \u03b1-synuclein and phosphorylated Serine-129 \u03b1-synuclein in male and female mice overexpressing human \u03b1-synuclein. J Alzheimers Dis. 2021;79(2):875\u201393. https:\/\/doi.org\/10.3233\/JAD-200983.","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"38_CR203","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/ncb437","volume":"9","author":"N Rosenthal","year":"2007","unstructured":"Rosenthal N, Brown S. The mouse ascending: perspectives for human-disease models. Nat Cell Biol. 2007;9(9):993\u20139. https:\/\/doi.org\/10.1038\/ncb437.","journal-title":"Nat Cell Biol"},{"issue":"6","key":"38_CR204","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/ame2.12487","volume":"7","author":"S Neziri","year":"2024","unstructured":"Neziri S, K\u00f6seo\u011flu AE, Deniz K\u00f6seo\u011flu G, \u00d6zg\u00fcltekin B, \u00d6zgent\u00fcrk N\u00d6. Animal models in neuroscience with alternative approaches: evolutionary, biomedical, and ethical perspectives. Anim Models Exp Med. 2024;7(6):868\u201380. https:\/\/doi.org\/10.1002\/ame2.12487.","journal-title":"Anim Models Exp Med"},{"key":"38_CR205","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-323-85555-6.00002-3","volume":"193","author":"E Simons","year":"2023","unstructured":"Simons E, Fleming SM. Role of rodent models in advancing precision medicine for Parkinson\u2019s disease. Handb Clin Neurol. 2023;193:3\u201316. https:\/\/doi.org\/10.1016\/B978-0-323-85555-6.00002-3.","journal-title":"Handb Clin Neurol."},{"issue":"3","key":"38_CR206","doi-asserted-by":"publisher","first-page":"139","DOI":"10.14802\/jmd.19046","volume":"12","author":"HK Chung","year":"2019","unstructured":"Chung HK, Ho HA, P\u00e9rez-Acu\u00f1a D, Lee SJ. Modeling \u03b1-synuclein propagation with preformed fibril injections. J Mov Disord. 2019;12(3):139\u201351. https:\/\/doi.org\/10.14802\/jmd.19046.","journal-title":"J Mov Disord"},{"issue":"9","key":"38_CR207","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1084\/jem.20160368","volume":"213","author":"NL Rey","year":"2016","unstructured":"Rey NL, Steiner JA, Maroof N, Luk KC, Madaj Z, Trojanowski JQ, et al. Widespread transneuronal propagation of \u03b1-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson\u2019s disease. J Exp Med. 2016;213(9):1759\u201378. https:\/\/doi.org\/10.1084\/jem.20160368.","journal-title":"J Exp Med"},{"issue":"6","key":"38_CR208","doi-asserted-by":"publisher","DOI":"10.1007\/s00429-025-02959-9","volume":"230","author":"A Vaquero-Rodr\u00edguez","year":"2025","unstructured":"Vaquero-Rodr\u00edguez A, Razquin J, Murueta-Goyena A, Miguelez C, Ru\u00edz-Ortega J\u00c1, Lafuente JV, et al. Temporal progression of pathological features in an \u03b1-synuclein overexpression model of Parkinson\u2019s disease. Brain Struct Funct. 2025;230(6):91. https:\/\/doi.org\/10.1007\/s00429-025-02959-9.","journal-title":"Brain Struct Funct"},{"issue":"1","key":"38_CR209","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-01073-1","volume":"11","author":"L Miquel-Rio","year":"2025","unstructured":"Miquel-Rio L, Jeric\u00f3-Escolar J, Sarri\u00e9s-Serrano U, Yanes-Castilla C, Torres-L\u00f3pez M, Argibay U, et al. Early synaptic changes and reduced brain connectivity in PD-like mice with depressive phenotype. npj Park Dis. 2025;11(1):242. https:\/\/doi.org\/10.1038\/s41531-025-01073-1.","journal-title":"npj Park Dis"},{"issue":"6","key":"38_CR210","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3233\/JPD-240207","volume":"14","author":"A Bj\u00f6rklund","year":"2024","unstructured":"Bj\u00f6rklund A, Mattsson B. The AAV-\u03b1-Synuclein model of Parkinson\u2019s disease: an update. J Parkinsons Dis. 2024;14(6):1077\u201394. https:\/\/doi.org\/10.3233\/JPD-240207.","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"38_CR211","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10020119","volume":"10","author":"BA Perez","year":"2020","unstructured":"Perez BA, Shutterly A, Chan YK, Byrne BJ, Corti M. Management of neuroinflammatory responses to AAV-mediated gene therapies for neurodegenerative diseases. Brain Sci. 2020;10(2):119. https:\/\/doi.org\/10.3390\/brainsci10020119.","journal-title":"Brain Sci"},{"key":"38_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115363","volume":"211","author":"D Ye","year":"2024","unstructured":"Ye D, Chukwu C, Yang Y, Hu Z, Chen H. Adeno-associated virus vector delivery to the brain: technology advancements and clinical applications. Adv Drug Deliv Rev. 2024;211:115363. https:\/\/doi.org\/10.1016\/j.addr.2024.115363.","journal-title":"Adv Drug Deliv Rev"},{"key":"38_CR213","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1432342","volume":"15","author":"A Freuchet","year":"2024","unstructured":"Freuchet A, Pin\u00e7on A, Sette A, Lindestam Arlehamn CS. Inflammation and heterogeneity in synucleinopathies. Front Immunol. 2024;15:1432342. https:\/\/doi.org\/10.3389\/fimmu.2024.1432342.","journal-title":"Front Immunol"},{"key":"38_CR214","doi-asserted-by":"publisher","unstructured":"Karikari AA, Koprich JB, Ip CW. Generation and analysis of viral vector-mediated rodent models for Parkinson\u2019s disease. In: Bartels T, editor. Alpha-synuclein: methods and protocols [Internet]. New York, NY: Springer; 2019 [cited 2026 Mar 3]. p. 271\u201386. Available from: https:\/\/doi.org\/10.1007\/978-1-4939-9124-2_21","DOI":"10.1007\/978-1-4939-9124-2_21"},{"key":"38_CR215","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578047","volume":"376","author":"DL Heiden","year":"2023","unstructured":"Heiden DL, Monogue B, Ali MH, Beckham JD. A functional role for Alpha-synuclein in neuroimmune responses. J Neuroimmunol. 2023;376:578047. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578047.","journal-title":"J Neuroimmunol"},{"issue":"43","key":"38_CR216","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn1298","volume":"8","author":"I Choi","year":"2022","unstructured":"Choi I, Heaton GR, Lee YK, Yue Z. Regulation of \u03b1-synuclein homeostasis and inflammasome activation by microglial autophagy. Sci Adv. 2022;8(43):eabn1298. https:\/\/doi.org\/10.1126\/sciadv.abn1298.","journal-title":"Sci Adv"},{"issue":"1","key":"38_CR217","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2534","volume":"4","author":"C Kim","year":"2013","unstructured":"Kim C, Ho DH, Suk JE, You S, Michael S, Kang J, et al. Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun. 2013;4(1):1562. https:\/\/doi.org\/10.1038\/ncomms2534.","journal-title":"Nat Commun"},{"key":"38_CR218","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104525","volume":"130","author":"JR Patterson","year":"2019","unstructured":"Patterson JR, Duffy MF, Kemp CJ, Howe JW, Collier TJ, Stoll AC, et al. Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal \u03b1-synuclein preformed fibrils. Neurobiol Dis. 2019;130:104525. https:\/\/doi.org\/10.1016\/j.nbd.2019.104525.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"38_CR219","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3233\/JPD-212847","volume":"11","author":"NK Polinski","year":"2021","unstructured":"Polinski NK. A summary of phenotypes observed in the in vivo rodent Alpha-Synuclein preformed fibril model. J Park Dis. 2021;11(4):1555\u201367. https:\/\/doi.org\/10.3233\/JPD-212847.","journal-title":"J Park Dis"},{"issue":"27","key":"38_CR220","doi-asserted-by":"publisher","first-page":"10392","DOI":"10.1074\/jbc.RA119.007743","volume":"294","author":"JM Froula","year":"2019","unstructured":"Froula JM, Castellana-Cruz M, Anabtawi NM, Camino JD, Chen SW, Thrasher DR, et al. Defining \u03b1-synuclein species responsible for Parkinson\u2019s disease phenotypes in mice. J Biol Chem. 2019;294(27):10392\u2013406. https:\/\/doi.org\/10.1074\/jbc.RA119.007743.","journal-title":"J Biol Chem"},{"issue":"26","key":"38_CR221","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2011196118","volume":"118","author":"S Zhang","year":"2021","unstructured":"Zhang S, Liu YQ, Jia C, Lim YJ, Feng G, Xu E, et al. Mechanistic basis for receptor-mediated pathological \u03b1-synuclein fibril cell-to-cell transmission in Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2021;118(26):e2011196118. https:\/\/doi.org\/10.1073\/pnas.2011196118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"38_CR222","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114745","volume":"13","author":"M Emmenegger","year":"2021","unstructured":"Emmenegger M, De Cecco E, Hruska\u2010Plochan M, Eninger T, Schneider MM, Barth M, et al. LAG3 is not expressed in human and murine neurons and does not modulate \u03b1\u2010synucleinopathies. EMBO Mol Med. 2021;13(9):EMMM202114745. https:\/\/doi.org\/10.15252\/emmm.202114745.","journal-title":"EMBO Mol Med"},{"issue":"9","key":"38_CR223","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00109-019-01810-z","volume":"97","author":"C Han","year":"2019","unstructured":"Han C, Xiong N, Guo X, Huang J, Ma K, Liu L, et al. Exosomes from patients with Parkinson\u2019s disease are pathological in mice. J Mol Med. 2019;97(9):1329\u201344. https:\/\/doi.org\/10.1007\/s00109-019-01810-z.","journal-title":"J Mol Med"},{"key":"38_CR224","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00246","author":"M Karampetsou","year":"2020","unstructured":"Karampetsou M, Sykioti VS, Leandrou E, Melachroinou K, Lambiris A, Giannelos A, et al. Intrastriatal administration of exosome-associated pathological alpha-synuclein is not sufficient by itself to cause pathology transmission. Front Neurosci. 2020. https:\/\/doi.org\/10.3389\/fnins.2020.00246.","journal-title":"Front Neurosci"},{"key":"38_CR225","doi-asserted-by":"crossref","unstructured":"Yang X, Jeong D, Madeo G, Kumbhar R, Wang N, Niu L, et al. Neuronal LAG3 facilitates pathogenic \u03b1-synuclein neuron-to-neuron propagation [Internet]. bioRxiv; 2025 [cited 2025 Dec 10]. p. 2025.01.03.631221. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2025.01.03.631221v1","DOI":"10.1101\/2025.01.03.631221"},{"issue":"7","key":"38_CR226","doi-asserted-by":"publisher","DOI":"10.3390\/biom11070931","volume":"11","author":"SO Hoppe","year":"2021","unstructured":"Hoppe SO, Uzuno\u011flu G, Nussbaum-Krammer C. \u03b1-Synuclein strains: does amyloid conformation explain the heterogeneity of synucleinopathies? Biomolecules. 2021;11(7):931. https:\/\/doi.org\/10.3390\/biom11070931.","journal-title":"Biomolecules"},{"key":"38_CR227","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.737195","author":"K Malfertheiner","year":"2021","unstructured":"Malfertheiner K, Stefanova N, Heras-Garvin A. The concept of \u03b1-synuclein strains and how different conformations may explain distinct neurodegenerative disorders. Front Neurol. 2021. https:\/\/doi.org\/10.3389\/fneur.2021.737195.","journal-title":"Front Neurol"},{"issue":"1","key":"38_CR228","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","volume":"23","author":"A Lau","year":"2020","unstructured":"Lau A, So RWL, Lau HHC, Sang JC, Ruiz-Riquelme A, Fleck SC, et al. \u03b1-Synuclein strains target distinct brain regions and cell types. Nat Neurosci. 2020;23(1):21\u201331. https:\/\/doi.org\/10.1038\/s41593-019-0541-x.","journal-title":"Nat Neurosci"},{"issue":"5","key":"38_CR229","doi-asserted-by":"publisher","first-page":"716","DOI":"10.15252\/emmm.201607305","volume":"9","author":"S Blumenstock","year":"2017","unstructured":"Blumenstock S, Rodrigues EF, Peters F, Blazquez\u2010Llorca L, Schmidt F, Giese A, et al. Seeding and transgenic overexpression of alpha\u2010synuclein triggers dendritic spine pathology in the neocortex. EMBO Mol Med. 2017;9(5):716\u201331. https:\/\/doi.org\/10.15252\/emmm.201607305.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"38_CR230","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0587-0","volume":"6","author":"A Okuzumi","year":"2018","unstructured":"Okuzumi A, Kurosawa M, Hatano T, Takanashi M, Nojiri S, Fukuhara T, et al. Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment. Acta Neuropathol Commun. 2018;6(1):96. https:\/\/doi.org\/10.1186\/s40478-018-0587-0.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"38_CR231","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jsb.2018.04.003","volume":"206","author":"S Hwang","year":"2019","unstructured":"Hwang S, Fricke P, Zinke M, Giller K, Wall JS, Riedel D, et al. Comparison of the 3D structures of mouse and human \u03b1-synuclein fibrils by solid-state NMR and STEM. J Struct Biol. 2019;206(1):43\u20138. https:\/\/doi.org\/10.1016\/j.jsb.2018.04.003.","journal-title":"J Struct Biol"},{"issue":"44","key":"38_CR232","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq3539","volume":"10","author":"A Sokratian","year":"2024","unstructured":"Sokratian A, Zhou Y, Tatli M, Burbidge KJ, Xu E, Viverette E, et al. Mouse \u03b1-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases. Sci Adv. 2024;10(44):eadq3539. https:\/\/doi.org\/10.1126\/sciadv.adq3539.","journal-title":"Sci Adv"},{"issue":"9","key":"38_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadva.2025.100179","volume":"14","author":"M Pirhaghi","year":"2025","unstructured":"Pirhaghi M, Mamashli F, Davaeil B, Mohammad-Zaheri M, Mousavi-Jarrahi Z, Tatzelt J, et al. Hidden faces of alpha-synuclein: Cryo-EM revelation of fibril polymorphs driven by disease, mutations, and PTMs. BBA Adv. 2025;14(9):100179. https:\/\/doi.org\/10.1016\/j.bbadva.2025.100179.","journal-title":"BBA Adv"},{"issue":"1","key":"38_CR234","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05971-2","volume":"9","author":"B Li","year":"2018","unstructured":"Li B, Ge P, Murray KA, Sheth P, Zhang M, Nair G, et al. Cryo-EM of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel. Nat Commun. 2018;9(1):3609. https:\/\/doi.org\/10.1038\/s41467-018-05971-2.","journal-title":"Nat Commun"},{"issue":"1","key":"38_CR235","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/1873-3468.15048","volume":"599","author":"NL Yan","year":"2025","unstructured":"Yan NL, Candido F, Tse E, Melo AA, Prusiner SB, Mordes DA, et al. Cryo-EM structure of a novel \u03b1-synuclein filament subtype from Multiple System Atrophy. FEBS Lett. 2025;599(1):33\u201340. https:\/\/doi.org\/10.1002\/1873-3468.15048.","journal-title":"FEBS Lett"},{"issue":"7706","key":"38_CR236","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL, et al. Cellular milieu imparts distinct pathological \u03b1-synuclein strains in \u03b1-synucleinopathies. Nature. 2018;557(7706):558\u201363. https:\/\/doi.org\/10.1038\/s41586-018-0104-4.","journal-title":"Nature"},{"issue":"23","key":"38_CR237","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.172192","volume":"8","author":"R Chandra","year":"2023","unstructured":"Chandra R, Sokratian A, Chavez KR, King S, Swain SM, Snyder JC, et al. Gut mucosal cells transfer \u03b1-synuclein to the vagus nerve. JCI Insight. 2023;8(23):e172192. https:\/\/doi.org\/10.1172\/jci.insight.172192.","journal-title":"JCI Insight"},{"issue":"1","key":"38_CR238","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41401-023-01150-2","volume":"45","author":"ZX Yang","year":"2024","unstructured":"Yang ZX, Zhang Y, Wang Q, Zhang L, Liu YF, Zhang Y, et al. Addition of \u03b1-synuclein aggregates to the intestinal environment recapitulates Parkinsonian symptoms in model systems. Acta Pharmacol Sin. 2024;45(1):36\u201351. https:\/\/doi.org\/10.1038\/s41401-023-01150-2.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"38_CR239","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41593-024-01866-2","volume":"28","author":"X Yuan","year":"2025","unstructured":"Yuan X, Nie S, Yang Y, Liu C, Xia D, Meng L, et al. Propagation of pathologic \u03b1-synuclein from kidney to brain may contribute to Parkinson\u2019s disease. Nat Neurosci. 2025;28(3):577\u201388. https:\/\/doi.org\/10.1038\/s41593-024-01866-2.","journal-title":"Nat Neurosci"},{"issue":"112","key":"38_CR240","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.nbd.2018.01.008","volume":"1","author":"FP Manfredsson","year":"2018","unstructured":"Manfredsson FP, Luk KC, Benskey MJ, Gezer A, Garcia J, Kuhn NC, et al. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology. Neurobiol Dis. 2018;1(112):106\u201318. https:\/\/doi.org\/10.1016\/j.nbd.2018.01.008.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"38_CR241","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","volume":"138","author":"N Van Den Berge","year":"2019","unstructured":"Van Den Berge N, Ferreira N, Gram H, Mikkelsen TW, Alstrup AKO, Casadei N, et al. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta Neuropathol (Berl). 2019;138(4):535\u201350. https:\/\/doi.org\/10.1007\/s00401-019-02040-w.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"6","key":"38_CR242","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/brain\/awab061","volume":"144","author":"N Van Den Berge","year":"2021","unstructured":"Van Den Berge N, Ferreira N, Mikkelsen TW, Alstrup AKO, Tamg\u00fcney G, Karlsson P, et al. Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats. Brain. 2021;144(6):1853\u201368. https:\/\/doi.org\/10.1093\/brain\/awab061.","journal-title":"Brain"},{"issue":"21","key":"38_CR243","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1016\/j.neuron.2024.08.003","volume":"112","author":"J Xiang","year":"2024","unstructured":"Xiang J, Tang J, Kang F, Ye J, Cui Y, Zhang Z, et al. Gut-induced alpha-Synuclein and Tau propagation initiate Parkinson\u2019s and Alzheimer\u2019s disease co-pathology and behavior impairments. Neuron. 2024;112(21):3585-3601.e5. https:\/\/doi.org\/10.1016\/j.neuron.2024.08.003.","journal-title":"Neuron"},{"issue":"11","key":"38_CR244","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1523\/JNEUROSCI.5427-08.2009","volume":"29","author":"CY Chung","year":"2009","unstructured":"Chung CY, Koprich JB, Siddiqi H, Isacson O. Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV \u03b1-synucleinopathy. J Neurosci. 2009;29(11):3365\u201373. https:\/\/doi.org\/10.1523\/JNEUROSCI.5427-08.2009.","journal-title":"J Neurosci"},{"issue":"2","key":"38_CR245","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1523\/JNEUROSCI.4029-08.2009","volume":"29","author":"W Matsuda","year":"2009","unstructured":"Matsuda W, Furuta T, Nakamura KC, Hioki H, Fujiyama F, Arai R, et al. Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci. 2009;29(2):444\u201353. https:\/\/doi.org\/10.1523\/JNEUROSCI.4029-08.2009.","journal-title":"J Neurosci"},{"issue":"1","key":"38_CR246","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0587-0","volume":"6","author":"A Okuzumi","year":"2018","unstructured":"Okuzumi A, Kurosawa M, Hatano T, Takanashi M, Nojiri S, Fukuhara T, et al. Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment. Acta Neuropathol Commun. 2018;6(1):96. https:\/\/doi.org\/10.1186\/s40478-018-0587-0.","journal-title":"Acta Neuropathol Commun"},{"key":"38_CR247","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.nbd.2017.05.014","volume":"105","author":"H Abdelmotilib","year":"2017","unstructured":"Abdelmotilib H, Maltbie T, Delic V, Liu Z, Hu X, Fraser KB, et al. \u03b1-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic neurodegeneration. Neurobiol Dis. 2017;105:84\u201398. https:\/\/doi.org\/10.1016\/j.nbd.2017.05.014.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"38_CR248","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3233\/JPD-230129","volume":"14","author":"MA Weber","year":"2024","unstructured":"Weber MA, Kerr G, Thangavel R, Conlon MM, Gumusoglu SB, Gupta K, et al. Alpha-Synuclein pre-formed fibrils injected into prefrontal cortex primarily spread to cortical and subcortical structures. J Park Dis. 2024;14(1):81\u201394. https:\/\/doi.org\/10.3233\/JPD-230129.","journal-title":"J Park Dis"},{"issue":"3","key":"38_CR249","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00401-016-1661-y","volume":"133","author":"A Ulusoy","year":"2017","unstructured":"Ulusoy A, Phillips RJ, Helwig M, Klinkenberg M, Powley TL, Di Monte DA. Brain-to-stomach transfer of \u03b1-synuclein via vagal preganglionic projections. Acta Neuropathol (Berl). 2017;133(3):381\u201393. https:\/\/doi.org\/10.1007\/s00401-016-1661-y.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"1","key":"38_CR250","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"JR Mazzulli","year":"2011","unstructured":"Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, Caldwell GA, et al. Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell. 2011;146(1):37\u201352. https:\/\/doi.org\/10.1016\/j.cell.2011.06.001.","journal-title":"Cell"},{"issue":"1","key":"38_CR251","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20192193","volume":"218","author":"F Bassil","year":"2020","unstructured":"Bassil F, Meymand ES, Brown HJ, Xu H, Cox TO, Pattabhiraman S, et al. \u03b1-Synuclein modulates tau spreading in mouse brains. J Exp Med. 2020;218(1):e20192193. https:\/\/doi.org\/10.1084\/jem.20192193.","journal-title":"J Exp Med"},{"key":"38_CR252","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2026.107323","volume":"221","author":"JM Webster","year":"2026","unstructured":"Webster JM, Yang YT, Miller AT, Zane A, Scholz K, Stone WJ, et al. Tau, amyloid-\u03b2 and \u03b1-synuclein co-pathologies synergistically enhance neuroinflammation and hippocampal neuron loss. Neurobiol Dis. 2026;221:107323. https:\/\/doi.org\/10.1016\/j.nbd.2026.107323.","journal-title":"Neurobiol Dis"},{"key":"38_CR253","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106010","volume":"178","author":"S Lin","year":"2023","unstructured":"Lin S, Leit\u00e3o ADG, Fang S, Gu Y, Barber S, Gilliard-Telefoni R, et al. Overexpression of alpha synuclein disrupts APP and endolysosomal axonal trafficking in a mouse model of synucleinopathy. Neurobiol Dis. 2023;178:106010. https:\/\/doi.org\/10.1016\/j.nbd.2023.106010.","journal-title":"Neurobiol Dis"},{"issue":"10","key":"38_CR254","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1002\/mds.29161","volume":"37","author":"M Sawamura","year":"2022","unstructured":"Sawamura M, Onoe H, Tsukada H, Isa K, Yamakado H, Okuda S, et al. Lewy Body disease primate model with \u03b1-Synuclein propagation from the olfactory bulb. Mov Disord. 2022;37(10):2033\u201344. https:\/\/doi.org\/10.1002\/mds.29161.","journal-title":"Mov Disord"},{"key":"38_CR255","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jneumeth.2015.07.025","volume":"255","author":"SC Vermilyea","year":"2015","unstructured":"Vermilyea SC, Emborg ME. \u03b1-Synuclein and nonhuman primate models of Parkinson\u2019s disease. J Neurosci Methods. 2015;255:38\u201351. https:\/\/doi.org\/10.1016\/j.jneumeth.2015.07.025.","journal-title":"J Neurosci Methods"},{"issue":"1","key":"38_CR256","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0413-0","volume":"5","author":"A Shimozawa","year":"2017","unstructured":"Shimozawa A, Ono M, Takahara D, Tarutani A, Imura S, Masuda-Suzukake M, et al. Propagation of pathological \u03b1-synuclein in marmoset brain. Acta Neuropathol Commun. 2017;5(1):12. https:\/\/doi.org\/10.1186\/s40478-017-0413-0.","journal-title":"Acta Neuropathol Commun"},{"issue":"11","key":"38_CR257","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1093\/brain\/awz296","volume":"142","author":"Y Chu","year":"2019","unstructured":"Chu Y, Muller S, Tavares A, Barret O, Alagille D, Seibyl J, et al. Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes. Brain. 2019;142(11):3565\u201379. https:\/\/doi.org\/10.1093\/brain\/awz296.","journal-title":"Brain"},{"issue":"5","key":"38_CR258","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/brain\/awaa096","volume":"143","author":"ML Arotcarena","year":"2020","unstructured":"Arotcarena ML, Dovero S, Prigent A, Bourdenx M, Camus S, Porras G, et al. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates. Brain. 2020;143(5):1462\u201375. https:\/\/doi.org\/10.1093\/brain\/awaa096.","journal-title":"Brain"},{"key":"38_CR259","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106086","volume":"180","author":"A Fayard","year":"2023","unstructured":"Fayard A, Fenyi A, Lavisse S, Dovero S, Bousset L, Bellande T, et al. Functional and neuropathological changes induced by injection of distinct alpha-synuclein strains: a pilot study in non-human primates. Neurobiol Dis. 2023;180:106086. https:\/\/doi.org\/10.1016\/j.nbd.2023.106086.","journal-title":"Neurobiol Dis"},{"issue":"20","key":"38_CR260","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz9165","volume":"6","author":"M Bourdenx","year":"2020","unstructured":"Bourdenx M, Nioche A, Dovero S, Arotcarena ML, Camus S, Porras G, et al. Identification of distinct pathological signatures induced by patient-derived \u03b1-synuclein structures in nonhuman primates. Sci Adv. 2020;6(20):eaaz9165. https:\/\/doi.org\/10.1126\/sciadv.aaz9165.","journal-title":"Sci Adv"},{"issue":"5","key":"38_CR261","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa2203395","volume":"387","author":"AE Lang","year":"2022","unstructured":"Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, et al. Trial of Cinpanemab in early Parkinson\u2019s disease. N Engl J Med. 2022;387(5):408\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2203395.","journal-title":"N Engl J Med"},{"issue":"1","key":"38_CR262","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00845-5","volume":"10","author":"G Pagano","year":"2024","unstructured":"Pagano G, Dam T, Kerchner GA, Galpern WR, Biagioni M, Karan R, et al. Biologically defined neuronal synuclein disease as a tool to advance drug development. npj Park Dis. 2024;10(1):235. https:\/\/doi.org\/10.1038\/s41531-024-00845-5.","journal-title":"npj Park Dis"},{"issue":"5","key":"38_CR263","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJMoa2202867","volume":"387","author":"G Pagano","year":"2022","unstructured":"Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, et al. Trial of prasinezumab in early-stage Parkinson\u2019s disease. N Engl J Med. 2022;387(5):421\u201332. https:\/\/doi.org\/10.1056\/NEJMoa2202867.","journal-title":"N Engl J Med"},{"issue":"5","key":"38_CR264","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf304","volume":"7","author":"C Shering","year":"2025","unstructured":"Shering C, Pomfret M, Kubiak RJ, Pouliquen IJ, Yin W, Simen A, et al. Phase 1, randomized trials of MEDI1341: cerebrospinal fluid free \u03b1-synuclein lowered by >50%. Brain Commun. 2025;7(5):fcaf304. https:\/\/doi.org\/10.1093\/braincomms\/fcaf304.","journal-title":"Brain Commun"},{"issue":"1","key":"38_CR265","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00849-1","volume":"11","author":"P Kallunki","year":"2025","unstructured":"Kallunki P, Sotty F, Will\u00e9n K, Lubas M, David L, Ambj\u00f8rn M, et al. Rational selection of the monoclonal \u03b1-synuclein antibody amlenetug (Lu AF82422) for the treatment of \u03b1-synucleinopathies. npj Park Dis. 2025;11(1):132. https:\/\/doi.org\/10.1038\/s41531-024-00849-1.","journal-title":"npj Park Dis"},{"issue":"6","key":"38_CR266","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/mds.29784","volume":"39","author":"L Buur","year":"2024","unstructured":"Buur L, Wiedemann J, Larsen F, Ben Alaya-Fourati F, Kallunki P, Ditlevsen DK, et al. Randomized phase I trial of the \u03b1-synuclein antibody Lu AF82422. Mov Disord. 2024;39(6):936\u201344. https:\/\/doi.org\/10.1002\/mds.29784.","journal-title":"Mov Disord"},{"issue":"161","key":"38_CR267","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105543","volume":"1","author":"E Nordstr\u00f6m","year":"2021","unstructured":"Nordstr\u00f6m E, Eriksson F, Sigvardson J, Johannesson M, Kasrayan A, Jones-Kostalla M, et al. ABBV-0805, a novel antibody selective for soluble aggregated \u03b1-synuclein, prolongs lifespan and prevents buildup of \u03b1-synuclein pathology in mouse models of Parkinson\u2019s disease. Neurobiol Dis. 2021;1(161):105543. https:\/\/doi.org\/10.1016\/j.nbd.2021.105543.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"38_CR268","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12967-023-04012-x","volume":"21","author":"B Xiao","year":"2023","unstructured":"Xiao B, Tan EK. Immunotherapy trials in Parkinson\u2019s disease: challenges. J Transl Med. 2023;21(1):178. https:\/\/doi.org\/10.1186\/s12967-023-04012-x.","journal-title":"J Transl Med"},{"issue":"7","key":"38_CR269","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/mds.29016","volume":"37","author":"HJ Yu","year":"2022","unstructured":"Yu HJ, Thijssen E, van Brummelen E, van der Plas JL, Radanovic I, Moerland M, et al. A randomized first\u2010in\u2010human study with UB\u2010312, a UBITh\u00ae \u03b1\u2010synuclein peptide vaccine. Mov Disord. 2022;37(7):1416\u201324. https:\/\/doi.org\/10.1002\/mds.29016.","journal-title":"Mov Disord"},{"issue":"1","key":"38_CR270","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00415-024-12770-x","volume":"272","author":"M Alfaidi","year":"2025","unstructured":"Alfaidi M, Barker RA, Kuan WL. An update on immune-based alpha-synuclein trials in Parkinson\u2019s disease. J Neurol. 2025;272(1):21. https:\/\/doi.org\/10.1007\/s00415-024-12770-x.","journal-title":"J Neurol"},{"issue":"7","key":"38_CR271","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1474-4422(20)30136-8","volume":"19","author":"D Volc","year":"2020","unstructured":"Volc D, Poewe W, Kutzelnigg A, L\u00fchrs P, Thun-Hohenstein C, Schneeberger A, et al. Safety and immunogenicity of the \u03b1-synuclein active immunotherapeutic PD01A in patients with Parkinson\u2019s disease: a randomised, single-blinded, phase 1 trial. Lancet Neurol. 2020;19(7):591\u2013600. https:\/\/doi.org\/10.1016\/S1474-4422(20)30136-8.","journal-title":"Lancet Neurol"},{"key":"38_CR272","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174262","volume":"907","author":"ST Feng","year":"2021","unstructured":"Feng ST, Wang ZZ, Yuan YH, Wang XL, Guo ZY, Hu JH, et al. Inhibition of dynamin-related protein 1 ameliorates the mitochondrial ultrastructure via PINK1 and Parkin in the mice model of Parkinson\u2019s disease. Eur J Pharmacol. 2021;907:174262. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174262.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"38_CR273","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-00926-z","volume":"11","author":"X Yang","year":"2025","unstructured":"Yang X, Ma Z, Lian P, Wu Y, Liu K, Zhang Z, et al. Disruption of axonal transport in Parkinson\u2019s disease: the role of pathological \u03b1-Syn and AMPK\/p38 MAPK signaling. npj Parkinsons Dis. 2025;11(1):114. https:\/\/doi.org\/10.1038\/s41531-025-00926-z.","journal-title":"npj Parkinsons Dis"},{"issue":"1","key":"38_CR274","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-021-00776-9","volume":"14","author":"C Zhu","year":"2021","unstructured":"Zhu C, Bilousova T, Focht S, Jun M, Elias CJ, Melnik M, et al. Pharmacological inhibition of nSMase2 reduces brain exosome release and \u03b1-synuclein pathology in a Parkinson\u2019s disease model. Mol Brain. 2021;14(1):70. https:\/\/doi.org\/10.1186\/s13041-021-00776-9.","journal-title":"Mol Brain"},{"key":"38_CR275","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.852003","volume":"13","author":"S Menon","year":"2022","unstructured":"Menon S, Armstrong S, Hamzeh A, Visanji NP, Sardi SP, Tandon A. Alpha-Synuclein targeting therapeutics for Parkinson\u2019s Disease and related synucleinopathies. Front Neurol. 2022;13:852003. https:\/\/doi.org\/10.3389\/fneur.2022.852003.","journal-title":"Front Neurol"},{"issue":"1","key":"38_CR276","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52598-4","volume":"9","author":"G T\u00f3th","year":"2019","unstructured":"T\u00f3th G, Neumann T, Berthet A, Masliah E, Spencer B, Tao J, et al. Novel small molecules targeting the intrinsically disordered structural ensemble of \u03b1-synuclein protect against diverse \u03b1-synuclein mediated dysfunctions. Sci Rep. 2019;9(1):16947. https:\/\/doi.org\/10.1038\/s41598-019-52598-4.","journal-title":"Sci Rep"},{"key":"38_CR277","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1155753","author":"R Staats","year":"2023","unstructured":"Staats R, Brotzakis ZF, Chia S, Horne RI, Vendruscolo M. Optimization of a small molecule inhibitor of secondary nucleation in \u03b1-synuclein aggregation. Front Mol Biosci. 2023. https:\/\/doi.org\/10.3389\/fmolb.2023.1155753.","journal-title":"Front Mol Biosci"},{"issue":"6","key":"38_CR278","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","volume":"125","author":"J Wagner","year":"2013","unstructured":"Wagner J, Ryazanov S, Leonov A, Levin J, Shi S, Schmidt F, et al. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease. Acta Neuropathol (Berl). 2013;125(6):795\u2013813. https:\/\/doi.org\/10.1007\/s00401-013-1114-9.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"1","key":"38_CR279","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32797-w","volume":"13","author":"L Antonschmidt","year":"2022","unstructured":"Antonschmidt L, Matthes D, Dervi\u015fo\u011flu R, Frieg B, Dienemann C, Leonov A, et al. The clinical drug candidate anle138b binds in a cavity of lipidic \u03b1-synuclein fibrils. Nat Commun. 2022;13(1):5385. https:\/\/doi.org\/10.1038\/s41467-022-32797-w.","journal-title":"Nat Commun"},{"issue":"1","key":"38_CR280","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34490-9","volume":"8","author":"DL Price","year":"2018","unstructured":"Price DL, Koike MA, Khan A, Wrasidlo W, Rockenstein E, Masliah E, et al. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson\u2019s disease. Sci Rep. 2018;8(1):16165. https:\/\/doi.org\/10.1038\/s41598-018-34490-9.","journal-title":"Sci Rep"},{"issue":"1","key":"38_CR281","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00552-7","volume":"9","author":"DL Price","year":"2023","unstructured":"Price DL, Khan A, Angers R, Cardenas A, Prato MK, Bani M, et al. In vivo effects of the alpha-synuclein misfolding inhibitor Minzasolmin supports clinical development in Parkinson\u2019s disease. npj Park Dis. 2023;9(1):114. https:\/\/doi.org\/10.1038\/s41531-023-00552-7.","journal-title":"npj Park Dis"},{"issue":"41","key":"38_CR282","doi-asserted-by":"publisher","first-page":"10481","DOI":"10.1073\/pnas.1804198115","volume":"115","author":"J Pujols","year":"2018","unstructured":"Pujols J, Pe\u00f1a-D\u00edaz S, L\u00e1zaro DF, Peccati F, Pinheiro F, Gonz\u00e1lez D, et al. Small molecule inhibits \u03b1-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Proc Natl Acad Sci U S A. 2018;115(41):10481\u20136. https:\/\/doi.org\/10.1073\/pnas.1804198115.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"38_CR283","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18689-x","volume":"11","author":"N Bengoa-Vergniory","year":"2020","unstructured":"Bengoa-Vergniory N, Faggiani E, Ramos-Gonzalez P, Kirkiz E, Connor-Robson N, Brown LV, et al. CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson\u2019s disease. Nat Commun. 2020;11(1):4885. https:\/\/doi.org\/10.1038\/s41467-020-18689-x.","journal-title":"Nat Commun"},{"issue":"8","key":"38_CR284","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.110449","volume":"301","author":"L Shen","year":"2025","unstructured":"Shen L, Zhang J, Wang Z, Liu Y, Cui S, Rao H. Targeted degradation of \u03b1-synuclein by arginine-based PROTACs. J Biol Chem. 2025;301(8):110449. https:\/\/doi.org\/10.1016\/j.jbc.2025.110449.","journal-title":"J Biol Chem"},{"issue":"1","key":"38_CR285","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00630-7","volume":"18","author":"J Lee","year":"2023","unstructured":"Lee J, Sung KW, Bae EJ, Yoon D, Kim D, Lee JS, et al. Targeted degradation of \u237a-synuclein aggregates in Parkinson\u2019s disease using the AUTOTAC technology. Mol Neurodegener. 2023;18(1):41. https:\/\/doi.org\/10.1186\/s13024-023-00630-7.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"38_CR286","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70124","volume":"169","author":"MS Ho","year":"2025","unstructured":"Ho MS. Clearance pathways for \u03b1-Synuclein in Parkinson\u2019s disease. J Neurochem. 2025;169(6):e70124. https:\/\/doi.org\/10.1111\/jnc.70124.","journal-title":"J Neurochem"},{"issue":"24","key":"38_CR287","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1080\/17568919.2024.2431477","volume":"16","author":"SJ Liu","year":"2024","unstructured":"Liu SJ, Cai C, Zhu HP, Li X, Han B. Autophagy degradation: a promising dimension in drug discovery for neurodegenerative diseases. Future Med Chem. 2024;16(24):2563\u20135. https:\/\/doi.org\/10.1080\/17568919.2024.2431477.","journal-title":"Future Med Chem"},{"key":"38_CR288","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.expneurol.2017.10.003","volume":"298","author":"P Brundin","year":"2017","unstructured":"Brundin P, Dave KD, Kordower JH. Therapeutic approaches to target alpha-synuclein pathology. Exp Neurol Transl Sci Adv Dis-Modifying Ther Parkinson\u2019s Dis. 2017;298:225\u201335. https:\/\/doi.org\/10.1016\/j.expneurol.2017.10.003.","journal-title":"Exp Neurol Transl Sci Adv Dis-Modifying Ther Parkinson\u2019s Dis"},{"issue":"1","key":"38_CR289","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/nan.12312","volume":"42","author":"E Valera","year":"2016","unstructured":"Valera E, Monzio Compagnoni G, Masliah E. Review: novel treatment strategies targeting alpha-synuclein in multiple system atrophy as a model of synucleinopathy. Neuropathol Appl Neurobiol. 2016;42(1):95\u2013106. https:\/\/doi.org\/10.1111\/nan.12312.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"38_CR290","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/15548627.2023.2274711","volume":"20","author":"J Lee","year":"2024","unstructured":"Lee J, Yoon D, Sung KW, Bae EJ, Park DH, Suh YH, et al. Targeted degradation of SNCA\/\u03b1-synuclein aggregates in neurodegeneration using the AUTOTAC chemical platform. Autophagy. 2024;20(2):463\u20135. https:\/\/doi.org\/10.1080\/15548627.2023.2274711.","journal-title":"Autophagy"},{"issue":"3","key":"38_CR291","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030839","volume":"15","author":"S Pe\u00f1a-D\u00edaz","year":"2023","unstructured":"Pe\u00f1a-D\u00edaz S, Garc\u00eda-Pardo J, Ventura S. Development of small molecules targeting \u03b1-synuclein aggregation: a promising strategy to treat Parkinson\u2019s disease. Pharmaceutics. 2023;15(3):839. https:\/\/doi.org\/10.3390\/pharmaceutics15030839.","journal-title":"Pharmaceutics"},{"issue":"12","key":"38_CR292","doi-asserted-by":"publisher","first-page":"7926","DOI":"10.1021\/acs.jmedchem.3c00274","volume":"66","author":"Y Tong","year":"2023","unstructured":"Tong Y, Zhu W, Chen J, Wen T, Xu F, Pang J. Discovery of small-molecule degraders for Alpha-Synuclein aggregates. J Med Chem. 2023;66(12):7926\u201342. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c00274.","journal-title":"J Med Chem"},{"issue":"7","key":"38_CR293","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/mds.29346","volume":"38","author":"JM den Heijer","year":"2023","unstructured":"den Heijer JM, Kruithof AC, Moerland M, Walker M, Dudgeon L, Justman C, et al. A phase 1B trial in GBA1-associated Parkinson\u2019s disease of BIA-28-6156, a glucocerebrosidase activator. Mov Disord. 2023;38(7):1197\u2013208. https:\/\/doi.org\/10.1002\/mds.29346.","journal-title":"Mov Disord"},{"issue":"2","key":"38_CR294","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/mds.70111","volume":"41","author":"R Pozzi","year":"2026","unstructured":"Pozzi R, De Sciscio M, Bosetti M, Cano-Crespo S, Taylor J, Ignoni T, et al. Glucocerebrosidase target engagement and therapeutic plasma and cerebrospinal fluid levels after GT-02287 administration in healthy volunteers. Mov Disord. 2026;41(2):522\u20137. https:\/\/doi.org\/10.1002\/mds.70111.","journal-title":"Mov Disord"},{"issue":"1","key":"38_CR295","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-026-01275-1","volume":"12","author":"H Sarva","year":"2026","unstructured":"Sarva H, Pahwa R, Hernandez-Vara J, Goldstein MA, Borgohain R, Factor SA, et al. Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson\u2019s disease: a phase 2, randomized, double-blind, placebo-controlled study. npj Parkinsons Dis. 2026;12(1):62. https:\/\/doi.org\/10.1038\/s41531-026-01275-1.","journal-title":"npj Parkinsons Dis"},{"issue":"4","key":"38_CR296","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41573-024-01105-0","volume":"24","author":"O Antico","year":"2025","unstructured":"Antico O, Thompson PW, Hertz NT, Muqit MMK, Parton LE. Targeting mitophagy in neurodegenerative diseases. Nat Rev Drug Discov. 2025;24(4):276\u201399. https:\/\/doi.org\/10.1038\/s41573-024-01105-0.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"38_CR297","doi-asserted-by":"publisher","first-page":"6","DOI":"10.20517\/and.2024.33","volume":"5","author":"X Zhang","year":"2025","unstructured":"Zhang X, Zhang H, Dong J, Cai H, Le W. Advances in autophagy for Parkinson\u2019s disease pathogenesis and treatment. Ageing Neurodegener Dis. 2025;5(1):6. https:\/\/doi.org\/10.20517\/and.2024.33.","journal-title":"Ageing Neurodegener Dis"},{"issue":"1","key":"38_CR298","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00676-w","volume":"7","author":"L Sun","year":"2021","unstructured":"Sun L, Jiang WW, Wang Y, Yuan YS, Rong Z, Wu J, et al. Phosphorylated \u03b1-synuclein aggregated in Schwann cells exacerbates peripheral neuroinflammation and nerve dysfunction in Parkinson\u2019s disease through TLR2\/NF-\u03baB pathway. Cell Death Discov. 2021;7(1):289. https:\/\/doi.org\/10.1038\/s41420-021-00676-w.","journal-title":"Cell Death Discov"},{"issue":"1","key":"38_CR299","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0455-9","volume":"12","author":"C Kim","year":"2015","unstructured":"Kim C, Ojo-Amaize E, Spencer B, Rockenstein E, Mante M, Desplats P, et al. Hypoestoxide reduces neuroinflammation and \u03b1-synuclein accumulation in a mouse model of Parkinson\u2019s disease. J Neuroinflammation. 2015;12(1):236. https:\/\/doi.org\/10.1186\/s12974-015-0455-9.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"38_CR300","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0320-x","volume":"12","author":"E Valera","year":"2015","unstructured":"Valera E, Mante M, Anderson S, Rockenstein E, Masliah E. Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson\u2019s disease. J Neuroinflammation. 2015;12(1):93. https:\/\/doi.org\/10.1186\/s12974-015-0320-x.","journal-title":"J Neuroinflammation"},{"issue":"12","key":"38_CR301","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1093\/brain\/awab214","volume":"144","author":"A Khan","year":"2021","unstructured":"Khan A, Johnson R, Wittmer C, Maile M, Tatsukawa K, Wong JL, et al. NPT520-34 improves neuropathology and motor deficits in a transgenic mouse model of Parkinson\u2019s disease. Brain. 2021;144(12):3692\u2013709. https:\/\/doi.org\/10.1093\/brain\/awab214.","journal-title":"Brain"},{"key":"38_CR302","unstructured":"Akter DF. Effect of melatonin on oxidative stress parameters in levodopa-treated Parkinson\u2019s disease patients: a randomized, double-blind, placebo-controlled trial. [Clinical trial registration] [Internet]. clinicaltrials.gov; 2026 Jan [cited 2026 Apr 8]. Report No.: NCT07375693. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07375693"},{"key":"38_CR303","unstructured":"Mandal P. Brain glutathione (GSH) enrichment through gamma-glutamylcysteine (GGC) supplementation in early Parkinson\u2019s disease patients for reduction of extrapyramidal motor disturbances and halting cognition decline: a pilot trial [Clinical trial registration] [Internet]. clinicaltrials.gov; 2026 Mar [cited 2026 Apr 8]. Report No.: NCT07064005. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07064005"},{"key":"38_CR304","doi-asserted-by":"publisher","DOI":"10.1016\/j.dscb.2024.100163","volume":"16","author":"D Baggett","year":"2024","unstructured":"Baggett D, Olson A, Parmar MS. Novel approaches targeting \u03b1-Synuclein for Parkinson\u2019s disease: current progress and future directions for the disease-modifying therapies. Brain Disord. 2024;16:100163. https:\/\/doi.org\/10.1016\/j.dscb.2024.100163.","journal-title":"Brain Disord"},{"key":"38_CR305","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00299","volume":"12","author":"CR Fields","year":"2019","unstructured":"Fields CR, Bengoa-Vergniory N, Wade-Martins R. Targeting Alpha-Synuclein as a therapy for Parkinson\u2019s disease. Front Mol Neurosci. 2019;12:299. https:\/\/doi.org\/10.3389\/fnmol.2019.00299.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"38_CR306","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00797-1","volume":"20","author":"G Kuo","year":"2025","unstructured":"Kuo G, Kumbhar R, Blair W, Dawson VL, Dawson TM, Mao X. Emerging targets of \u03b1-synuclein spreading in \u03b1-synucleinopathies: a review of mechanistic pathways and interventions. Mol Neurodegener. 2025;20(1):10. https:\/\/doi.org\/10.1186\/s13024-025-00797-1.","journal-title":"Mol Neurodegener"},{"key":"38_CR307","doi-asserted-by":"publisher","unstructured":"Normile D. Science [Internet]. 2024 [cited 2025 Dec 11]. Genetically engineered marmosets promise insight into early stages of Parkinson\u2019s. Available from: https:\/\/www.science.org\/content\/article\/genetically-engineered-marmosets-promise-insight-early-stages-parkinson-shttps:\/\/doi.org\/10.1126\/science.zoziwj1","DOI":"10.1126\/science.zoziwj1"},{"key":"38_CR308","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41551-025-01496-4","volume":"1","author":"R Andrews","year":"2025","unstructured":"Andrews R, Fu B, Toomey CE, Breiter JC, Lachica J, Beckwith JS, et al. Large-scale visualization of \u03b1-synuclein oligomers in Parkinson\u2019s disease brain tissue. Nat Biomed Eng. 2025;1:1\u201313. https:\/\/doi.org\/10.1038\/s41551-025-01496-4.","journal-title":"Nat Biomed Eng"},{"key":"38_CR309","doi-asserted-by":"crossref","unstructured":"The Michael J Fox Foundation PFF Standardization Consortium. Protocol for generation of pre-formed fibrils from alpha-synuclein monomer [Internet]. 2021 Aug 17 [cited 2025 Dec 15]. Available from: https:\/\/www.protocols.io\/view\/protocol-for-generation-of-pre-formed-fibrils-from-bws6pehe","DOI":"10.17504\/protocols.io.bws6pehe"}],"container-title":["Molecular Neurodegeneration Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44477-026-00038-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44477-026-00038-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44477-026-00038-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:47:12Z","timestamp":1781016432000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s44477-026-00038-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":309,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1186\/s44477-026-00038-9","relation":{},"ISSN":["3059-4944"],"issn-type":[{"value":"3059-4944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":".\u00a0Jacqueline Burre is an Editorial Board Member for Molecular Neurodegeneration Advances and was not involved in the editorial review or decisions regarding this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}